<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by infinome on Medium]]></title>
        <description><![CDATA[Stories by infinome on Medium]]></description>
        <link>https://medium.com/@InfinoMe?source=rss-35f9b5de680f------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/0*w1ZDqxCbV1MlYFjS.png</url>
            <title>Stories by infinome on Medium</title>
            <link>https://medium.com/@InfinoMe?source=rss-35f9b5de680f------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Mon, 16 Nov 2026 23:29:51 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@InfinoMe/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[The Methionine Code]]></title>
            <link>https://medium.com/@InfinoMe/the-methionine-code-3f6364e4657c?source=rss-35f9b5de680f------2</link>
            <guid isPermaLink="false">https://medium.com/p/3f6364e4657c</guid>
            <category><![CDATA[life-extension]]></category>
            <category><![CDATA[longevity]]></category>
            <category><![CDATA[mthfr]]></category>
            <category><![CDATA[immortality]]></category>
            <category><![CDATA[aging]]></category>
            <dc:creator><![CDATA[infinome]]></dc:creator>
            <pubDate>Sat, 03 Jun 2023 23:42:53 GMT</pubDate>
            <atom:updated>2023-06-24T22:20:57.294Z</atom:updated>
            <content:encoded><![CDATA[<p>Home link for this article : <a href="https://blog.infino.me/the-methionine-code/">https://blog.infino.me/the-methionine-code/</a></p><h3>Decoding the Underlying Meaning of Aging Clocks</h3><p>Much of this blog post was inspired by the wonderful conversations <a href="https://blog.infino.me/foresight-institute/">at the recent Foresight Longevity Frontiers conference</a>! I am forever in their debt for inspiring this analysis.</p><p>The desire to “live forever” is as old as mankind, with several stories of historical figures attempting to escape death. 2,000 years ago the Chinese emperor “Wan Hu” strapped some of the earliest fireworks under his chair and <a href="https://www.youtube.com/watch?v=lL_wf11uPmA">arguably become the first astronaut</a> in an attempt to escape to the immortal heavens. The Egyptian pharaohs also dreamed of a transition to an immortal afterlife, and thus built the great pyramids of Giza in order to facilitate that transition. I like to joke that this may have been the first ever “pyramid scheme”, although ChatGPT tells me the comparison is wrong. (buzzkill)</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*ZerXSXD_OWtmEuJD.png" /></figure><p>Those attempts at immortality in antiquity were clearly unsuccessful. In the 20th century however, mankind’s quest for longevity finally began to bear fruit. In the last 100 years, we have roughly doubled the human life expectancy, a notable acceleration in progress that has never been seen in <em>millions of years</em> of our species evolution. This should make you optimistic. If you are reading this, you have been born in a truly special time in our species history!</p><p>Now that we are in the 21st century, a new revolution has just started to map the underlying causes of aging itself. What will follow, moving forward, are unifying theories that link the slow progress of biological aging with the long-term development of disease. What a time to be alive!</p><h3>Diet, Metabolism, and Human Longevity</h3><p>With the sudden jump in lifespan over the last century, we are now seeing diseases of old age dominate as the top causes of death. Outside of the exciting longevity research field, more traditional clinical research has continued to slowly address the rising epidemic of metabolic syndrome and its associated sequelae : diabetes and obesity. These conditions underlie several diseases of aging, particularly heart disease, which kills the most people in modern countries. Obesity, in particular, is one of the strongest and earliest recognized biomarkers for predicting mortality. All of these diseases are associated with age, but can we find underlying mechanisms that tie them to aging itself? That’s what this post is all about.</p><h3>Caloric Restriction</h3><p>One of the oldest and most reproducible longevity interventions in lab animals is caloric restriction (CR). Some of the<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2884327/"> earliest work goes back to 1935</a>, when it was shown that CR can extend the lifespan of rats. It is overly-simplistic to assert that caloric restriction and obesity are on opposite ends of a continuum, yet it is clear that there is a connection here, of some sort, between diet, obesity, and longevity. At the very least, as one of the first documented longevity interventions, it makes sense why our healthcare system has focused so much on body weight as a preventative measure.</p><h4>Methionine Restriction</h4><p>In the 1990s, a new discovery was made that refined our understanding of calories and aging. In fact, the calories may not have had anything to do with it at all! Amazingly, there is a single essential constituent of our diets that, when restricted, produces many of the same benefits to health and longevity as caloric restriction. That molecule is methionine, one of the 9 essential amino acids (out of 20) that our bodies cannot synthesize from scratch, but are the building blocks our cells need to make all proteins.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/800/0*4kPMHZuhycfDQZQJ.png" /></figure><p>Methionine is also special in its own unique way, in that it is the <strong>first amino acid for every single protein</strong> your cells can make. It is the amino acid encoded by the start codon in every RNA transcript. Thus, without methionine, your cells can not even start to make any proteins.</p><p>Methionine restriction was first shown in 1994 to extend the lifespan of rats by 30%. Since this landmark study, similar lifespan extending effects have been shown in <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898468/">worms</a>, <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820698/">yeast</a>, <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350766/">fruit flies</a>, and mice. <a href="https://pubmed.ncbi.nlm.nih.gov/8001743/">A later study in rats</a> was able to demonstrate an amazing 44% increase in lifespan (See the curve below)</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/651/0*2wR9ga3PPmSpC6pX.png" /><figcaption>From the original study here : <a href="https://faseb.onlinelibrary.wiley.com/doi/10.1096/fasebj.8.15.8001743">https://faseb.onlinelibrary.wiley.com/doi/10.1096/fasebj.8.15.8001743</a></figcaption></figure><p>It should be pointed out that, although we cannot make our own methionine, the bacteria in our guts can! A <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898468/">neat study in c-elegans worms suggests that the diabetes drug metformin</a> may actually be exerting its lifespan-extending effect by inhibiting methionine metabolism in the gut bacteria of the worm, starving the worm of methionine! This is an interesting paper, as the mechanism of action of metformin has still yet to be agreed upon by the scientific community.</p><h3>Aging Clocks &amp; DNA Methylation</h3><p>The current revolution in aging biology is undoubtedly the <a href="https://www.technologyreview.com/2022/04/15/1050019/aging-clocks/">discovery of the “Aging clock”</a> by Steve Horvath. In a <a href="https://pubmed.ncbi.nlm.nih.gov/21731603/">landmark 2011 study</a>, Horvath discovered that you can accurately predict someones chronological age (within about 5 years!) by measuring a handful of methylation markers in the genome. Subsequent to this study, several other papers have developed better models that are even more accurate in predicting age and mortality. These developments have been coined by Horvath as the <a href="https://www.nature.com/articles/s41576-018-0004-3">Epigenetic Clock Theory of Aging</a>.</p><h3>Epigenetics : This is Your Genome on Meth!</h3><p>For those unfamiliar, a brief summary of “epigenetics” is the idea that the genome can be modified with markers that don’t affect the underlying sequence. These markers can regulate how DNA is unwound and whether or not specific proteins can bind to it, thereby <em>affecting what genes are activated</em>. As you can see in the wonderful animation by <a href="https://www.cellsignal.com/">Cell Signaling</a>, there are several such markers/reactions that are used to accomplish this. The aging clocks we are talking about focus on the “methylation” markers that are directly added to the DNA.</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2FTj_6DcUTRnM%3Ffeature%3Doembed&amp;display_name=YouTube&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DTj_6DcUTRnM&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2FTj_6DcUTRnM%2Fhqdefault.jpg&amp;key=a19fcc184b9711e1b4764040d3dc5c07&amp;type=text%2Fhtml&amp;schema=youtube" width="854" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/da06f40182d270854452a6f7b34f38fc/href">https://medium.com/media/da06f40182d270854452a6f7b34f38fc/href</a></iframe><p>Aging clocks work by measuring what sites in the genome have these methylation markers. There are an estimated <a href="https://academic.oup.com/nar/article/44/11/5123/2468268">28 million sites in the genome</a> that can have this modification, so the landscape is quite complex! Some of these sites are correlated with age, some are not. Some sites show increased methylation with age, and some decreased, but overall, computer models can be used to find the important ones that are the most predictive. Many groups have now demonstrated that a humans age can be guessed, to an accuracy of just a few years, by looking at a handful of these markers. Like counting tree rings!</p><p>The epigenetic theory of aging is a powerful new model to understand the potential “cause” of aging. It is generally accepted that epigenetic patterning in the genome help to determine a cells “identity” in the body. In fact, by<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056338/"> changing these methylation patterns, you can reprogram</a> cells to act like a different cell type. With regards to aging, its possible that <a href="https://www.youtube.com/watch?v=QRt7LjqJ45k">cells are “forgetting”, over time, how to properly behave in their particular local tissue environment</a>.</p><p>For an excellent review of Epigenetics and Aging clocks, check out the Sheekey Science show!</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2FwHJwWDe6DEo%3Ffeature%3Doembed&amp;display_name=YouTube&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DwHJwWDe6DEo&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2FwHJwWDe6DEo%2Fhqdefault.jpg&amp;key=a19fcc184b9711e1b4764040d3dc5c07&amp;type=text%2Fhtml&amp;schema=youtube" width="854" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/a045ad5091ec79f5eb6c51fe45cf8930/href">https://medium.com/media/a045ad5091ec79f5eb6c51fe45cf8930/href</a></iframe><p>Plenty of non-biologists read my blog, so a 1 paragraph reminder of the “central dogma of molecular biology” is in order. Our genes store the blueprints for making the protein machines in our cells. Our genes are kept locked up in the cell nucleus (as DNA) for safety, but when the cell needs to make a protein, a “copy” of that gene sequence is made with a slightly different molecule called messenger-RNA. That “mRNA” leaves the nucleus into the cell cytosol where it gets “translated” into a protein. All of this stuff must be tightly controlled and regulated, at every step! Methylation of DNA is one method of control, as we’ve now discussed. RNA must also be tightly regulated in the cell.</p><h3>RNA is methylated too!</h3><p>While DNA is hanging out in the cell nucleus, it can get methylated to control which genes get turned “on” in a particular cell. RNA molecules can also become methylated, and these markers have a regulatory role that controls how those mRNA transcripts are translated into proteins.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/685/0*Oo5qZWDQu__R9_gQ.png" /><figcaption>From this review : <a href="https://www.nature.com/articles/s41422-018-0040-8">https://www.nature.com/articles/s41422-018-0040-8</a></figcaption></figure><p>It has been known for decades that a large proportion of RNAs in the cell can be methylated, and the most common modification is the “m6A” methylated adenosine. This m6A marker is <a href="https://www.nature.com/articles/s41422-022-00725-8">added by a large “writer complex”</a> that is formed in the nucleus, right at the site where the mRNA is transcribed from the genome. (Remember this detail for later!) These RNA methylation markers can also be dynamically removed by a set of “eraser” enzymes and also recognized with a family of “reader” proteins.</p><p>So what do these methylations do? All kinds of things! They affect export from the nucleus into the cytosol, regulate translation, and mRNA stability/recycling by the cell. That is, RNA methylation, in general, is known to affect how long the RNA sticks around and how much protein is made with its code. If you are an engineer, you should probably be thinking of feedback right about now….</p><p>If DNA methylation is associated with aging, is it possible RNA methylation is too? That’s unclear, but I will demonstrate to you that both Obesity and Diabetes, both dominant diseases in the “metabolic syndrome”, have direct links to RNA methylation biology.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/850/0*NwkHCW3fVNsB5gi6.png" /><figcaption>From this paper : <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763108/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763108/</a></figcaption></figure><h3>The Genetics of Obesity &amp; RNA Methylation</h3><p>The <a href="https://en.wikipedia.org/wiki/Manhattan_plot">manhattan plot</a> below shows the genetic architecture of obesity. Several of the genes below (MC4R, POMC, and BDNF) have all been localized to a specific brain circuit (the arcuate nucleus of the hypothalamus) that regulates food intake and whole body metabolism. That story is an amazing triumph of science that I will write up some day, but it’s too much to discuss in this episode!</p><p>For now, we’re going to focus on the single most significant obesity gene locus, <strong>FTO</strong>.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/850/0*IKXqPjQPHgOhBmN4.png" /></figure><h3>FTO is an RNA m6a “Eraser”</h3><p>As previously discussed, N 6-methyladenosine ( <em>m6A</em>) is the <a href="https://www.nature.com/articles/s41392-020-00450-x">most abundant RNA modification</a> known in cells. When genes are transcribed into RNA copies, they are immediately methylated with an m6a “writer complex” that forms right at the site of transcription. This complex contains enzymes that transfer methyl groups from available S-adenosyl-methionine (SAM) directly onto the mRNA transcripts.</p><p>That <strong>FTO</strong> gene, the top genetic risk of obesity, has been found to be an mRNA methylation “eraser”. It hangs out in the nucleus and specifically removes m6A methylation markers from RNA strands. Whatever it is that RNA methylation is doing with respect to body mass, the FTO eraser counter-acts those modifications. Since its the dominant genetic risk factor for obesity, scientists know that it must be doing something critically important in regulating body mass. We just don’t yet understand the mechanism!</p><h4>FTO Also Erases the Special m6Am mRNA “Cap”</h4><p>RNA “m6a” modifications are the most abundant known changes to mRNA. They are found throughout the length of mRNA strands, but it is now known that some may be more important than others. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513158/">Recent work from the Jaffrey</a> lab in the last few years has found that a specific m6A site is of critical importance! This lab has shown that many mRNA transcripts start with a special m6A adenosine that has an extremely important role in the regulation of transcripts.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/842/0*wmcnsIucUQ36HgrK.png" /><figcaption>Figure from New England Biolabs : <a href="https://www.neb.com/products/rna-reagents/rna-synthesis/rna-synthesis/rna-capping">https://www.neb.com/products/rna-reagents/rna-synthesis/rna-synthesis/rna-capping</a></figcaption></figure><p>During transcription, both ends of mRNA strands are modified to facilitate their export and trafficking out of the cells nucleus. The “front” (5′) end of the mRNA strand has a “cap” molecule added to it consisting of a 7-methyl-guanosine nucleotide (7mg) with a bridge of 3 phosphates. After this bridge, the first nucleotides of the mRNA are typically modified as well. In many cases, the first nucleotide is commonly a methylated m6a adenosine, that is then methylated a second time on the ribose sugar. This special doubly-methylated m6a at the start of the mRNA sequence is known as an m6Am. The first “m” ( <strong>m</strong>6Am) refers to the methyl group added to the adenosine ring (as in other <strong>m</strong>6A nucleotides), while the second “m” (m6A <strong>m</strong>) refers to the ribose methylation added to the sugar backbone. Thus, m6Am.</p><p>The 6-methylguanosine “cap” has a critical function of protecting the mRNA strand from digestion by cellular ribonucleases, which would otherwise immediately start eating the mRNA from the 5′ end like a voraciously hungry piranha 🐟. Our cells are loaded with these RNA cleanup enzymes.</p><p>The cap isn’t permanent however. The cell eventually will need to completely degrade mRNA transcripts once it no longer needs to make that particular protein. To do this, the cell relies on the <a href="https://en.wikipedia.org/wiki/Messenger_RNA_decapping">DCP2 enzyme to perform RNA de-capping</a>. Once complete, the mRNA is readily destroyed by the ribonuclease piranhas 🐟.</p><p>While the 7mg cap’s mission is to protect the mRNA strand, it appears that the very first RNA nucleotide has a regulatory role in protecting the cap! <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513158/">Jaffrey et al showed that the first nucleotide, often a methylated m6Am, prevents the de-capping enzyme</a> from binding to the strand! He further went on to demonstrate that the dominant obesity gene, FTO, preferentially removes the methylation from that specific m6Am nucleotide! That is, the FTO gene is effectively a kill switch that marks RNA transcripts for destruction when they are no longer needed.</p><p>The mRNA cap has another function relevant to this discussion. It directly targets the RNA to the translation machinery of the cell. When the 7mg cap is present, it gets bound by a series of <a href="https://en.wikipedia.org/wiki/Cap_binding_complex">cap-binding complexes</a>. One such complex binds in the nucleus and helps to escort the mRNA out into the cytosol. Once in the cytosol, the eukaryotic initiation factor 4 (eIF4) complex instead binds to the mRNA cap, and this complex in turn binds to a ribosome pre-initiation complex that is standing by, waiting to make a protein! (That pre-initiation complex comes pre-loaded with a methionine-tRNA, ready to set down the foundation for a new protein!)</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/996/0*gx23bwWOhDAO8dDY.png" /><figcaption>From this paper, which determined the structure of the writer complex : <a href="https://www.science.org/doi/10.1126/science.aba4904">https://www.science.org/doi/10.1126/science.aba4904</a></figcaption></figure><p>So effectively, the 7-methyguanosine mRNA cap is rather critical for making proteins, and binds to cap binding complexes to facilitate these motions. When present, the mRNA gets trafficked to the ribosomes. The <em>other</em> key purpose of the 7mg cap is to protect the mRNA from degradation. Without that cap present, the mRNA would be rapidly attacked by mRNA nucleases that chew on the 5′ end of the RNA. When the cell is done with an mRNA transcript, it <a href="https://en.wikipedia.org/wiki/Messenger_RNA_decapping">“de-caps” it with the enzyme DCP2</a> so that it can be degraded by these enzymes.</p><p>RNA caps as translation “on switches”</p><p>This whole pathway is a bit roundabout, but here is my attempt to interpret what is going on. The RNA cap, defined by the special 7mg nucleotide, is akin to a molecular on-switch for that particular gene transcript. That cap functions by 1) blocking degradation by nucleases and 2) specifically binding the mRNA strand to the translation machinery. Removing that “on switch” with the mRNA de-capping mechanism is akin to disabling the need to make more of that gene into protein.</p><p>The m6Am nucleotide, often immediately flanking the 7mg cap, apparently resists decapping. The FTO gene, key to obesity, removes the N6-methyl group from that nucleotide, thus allowing decapping to proceed, which in turn immediately halts translation of that gene transcript.</p><p>Thinking of methionine again, as the origin of those methyl groups during transcription, is it possible that FTO here is acting as a cellular starvation sensor that immediately halts translation for particular genes?</p><h3>Evidence that FTO is a “Nutrient Sensor”</h3><p>Given that FTO is the most important gene in obesity, it would make obvious sense that it has something to do with sensing of available nutrients. Many in the literature have explored this possibility. Most interesting to me are the specific papers exploring its role in sensing<strong> protein</strong>.</p><p>In <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2668859/">one of the earliest characterizations of FTO’s enzymatic activity</a>, it was shown to be expressed throughout the body, but particularly abundant in the arcuate nucleus of the hypothalamus. The authors thus focused their attention there, since this is the same location where several other obesity-related genes (MC4R, POMC, BDNF) have been characterized. They determined that the enzyme is dependent on the cofactor 2-oxoglutarate, also known as alpha-ketoglutarate, a rate-limiting metabolite in the krebs cycle, and thus potentially an important sensor of mitochondrial metabolism. They also demonstrated that the expression levels of this gene vary widely with feeding status. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2668859/">FTO expression dropped 60% during a 48 hour fast in mice</a>! This hints that FTO could potentially be a sensor of starvation, and its role in that key hypothalamic nucleus could be central to regulating whole body metabolism and appetite.</p><p>This paper also discusses a key experiment involving leptin signaling. Since the arcuate nucleus of the hypothalamus is known to be responsible for sensing circulating leptin in the blood, a hormone produced by fat cells, the authors hypothesized that injecting leptin into starved mice might restore the levels of FTO expression. <strong>It did not</strong>, suggesting that FTO is not sensing stored body fat, but something else.</p><p>Years later, the same scientists showed that FTO expression was influenced by the<a href="https://pubmed.ncbi.nlm.nih.gov/23359686/"> availability of amino acids</a> in cells. In a second paper, they showed that FTO was specifically down-regulated <a href="https://pubmed.ncbi.nlm.nih.gov/22614055/">by the deprivation of <strong>essential</strong> amino acids</a>, as opposed to non-essential amino acids. They further tested a few specific combinations of amino acids, and found that depriving Methionine &amp; Cysteine, together, produced a substantial drop in FTO expression.</p><h4>A previous theory, that I am now second guessing!</h4><p>Four years ago I wrote about fascinating evidence that has accumulated that some <a href="https://blog.infino.me/greedy-fat-cells/">viruses can cause obesity in animals</a> by reprogramming fat cells. In that article, I also briefly touched upon the emerging field of study known as <a href="https://pubmed.ncbi.nlm.nih.gov/34205979/">viral epitranscriptomics</a>, which hypothesizes that RNA methylation evolved as a cellular antivirus defense. I think there still could be some overlapping explanations here, given that viruses may merely be hijacking cellular nutrient sensing in order to boost their replication.</p><p>I previously discussed RNA ribonucleases as the hungry cellular piranhas 🐟 that eat RNA molecules end-first with no delay! These ribonucleases are a key part of our cellular defense against RNA viruses, whose payloads we <strong>do not</strong> want to convert to proteins. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5218996/">The 7mg cap is thought by many to have potentially evolved for this purpose</a>. By relying on this mechanism to better distinguish cellular from viral mRNA, it is still possible that FTO plays a role in viral-induced obesity.</p><h3>The Genetics of Type 2 Diabetes &amp; RNA Methylation</h3><p>Obesity isn’t the only feature of metabolic syndrome. What about diabetes?!</p><p>In a previous blog post, I discussed the <a href="https://blog.infino.me/bpa/">genetic architecture of Type 2 Diabetes risk, and primarily focused on the top locus, <strong>TCF7L2</strong></a>, a fascinating transcription factor that regulates insulin signaling pathways. Its a fascinating story and I invite you to check it out, but there are many more loci in this Manhattan plot worth discussing.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*rPGvq-F-5BkGbhq2.png" /></figure><p>Besides the towering <strong>TCF7L2</strong> locus, several other can be seen. We can also see the obesity-associated <strong>FTO</strong> locus. Furthermore we also see the <a href="https://blog.infino.me/could-aging-be-an-infectious-disease/">CDK2N2A/2B locus, which is the key mediator of cellular senescence</a> and additionally the most associated locus with heart disease. These loci make sense given that obesity, diabetes, and heart disease are all comorbidities of the “metabolic syndrome” and tend to influence eachother. The CDKN2A locus also ties type 2 diabetes to what we know about cellular aging and senescence.</p><h3>CDKAL1 and IGFBP2 Genes are tied to RNA Methylation</h3><p>The <strong>CDKAL1</strong> locus is the second highest peak in this manhattan plot “skyline”. This is a fascinating enzyme that I will eventually need to devote an entire page to. The short story is that CDKAL1 is an RNA methyl-thiol transferase! It doesn’t just add a methyl, but a methyl plus a little extra sulfur group as well! Instead of modifying messenger RNAs (mRNAs) like FTO does, CDKAL1 modifies transfer RNAs (tRNAs) that are needed for protein translation!</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/800/0*ODlKb1uHZqtU0i3Y.png" /><figcaption>From this wonderful study that found this mechanism: <a href="https://www.nejm.org/doi/10.1056/NEJMcibr1109442">https://www.nejm.org/doi/10.1056/NEJMcibr1109442</a></figcaption></figure><p>Its not entirely obvious how this gene would relate to diabetes in particular, but the best evidence found thusfar is that the proper functioning of this gene is needed to <a href="https://www.frontiersin.org/articles/10.3389/fmolb.2020.584228/full">make functional insulin in the pancreas</a>. When this pathway breaks, the insulin protein is translated with errors that make it impossible to process into its active form. I’ll save the details for a future writeup.</p><p>Relevant to this discussion however, here we have yet another enzyme that adds a methyl group (plus an extra thiol) to a nucleic acid. Where does it get these parts? CDKAL1 is dependent on not one, but <strong>two</strong> <strong>S-adenosyl-methionine (SAM)</strong> donors to make this reaction work!</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/764/0*T4XuiQ46ego2MLSJ.png" /><figcaption>Source : <a href="https://www.nature.com/articles/s41586-021-03904-6">https://www.nature.com/articles/s41586-021-03904-6</a></figcaption></figure><p>The last locus I want to discuss is the<strong> IGF2BP2 gene</strong>. This locus is nowhere near as strong of a signal as <strong>TCF7L2</strong> or <strong>CDKAL1</strong> genes, but it turns out to be yet another m6a “reader” protein. That is, it binds to the same m6a methylation markers in mRNA transcripts that the FTO obesity gene removes. Most articles seem to suggest that the dominant role of the IGF2BP genes (1, 2, and 3) is to stabilize mRNA transcripts, which prevents their degradation.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/685/0*GePweBPkL_aK2eYF.png" /><figcaption>From this review : <a href="https://www.nature.com/articles/s41580-019-0168-5">https://www.nature.com/articles/s41580-019-0168-5</a></figcaption></figure><p><strong>Speculation zone</strong> : If <strong>IGF2BP2</strong> binds to mRNAs that are decorated with m6a methylation markers, this would seem to suggest that the more methylation on an mRNA transcript, the longer it “sticks around” to be made into proteins. Does this make sense? I would think so! If you have lots of methionine around you can make more proteins. If you are methionine starved, it might be time to recycle transcripts since the ribosomes won’t be able to translate them anyways. How does this relate to Type 2 Diabetes? I can only guess! From my time during my PhD studies of insulin signaling, it was really driven home to me that the insulin signaling axis controls both glucose uptake AND protein synthesis. When the body is starved of glucose, muscles become insulin resistant and break down their proteins so that amino acids can be sent to the liver, whereby they are converted into glucose in a process called gluconeogenesis. Glucose metabolism and protein synthesis/degradation are linked.</p><p>Similarly, in a methionine-deficient state, perhaps the <strong>CDKAL1</strong> gene evolved to sense this state and produces proinsulin that cannot be properly processed. Thereby reducing the insulin secretion and preparing the body to increase peripheral proteolysis and subsequent hepatic gluconeogenesis.</p><h3>Intermission</h3><p>So far we’ve discussed that our genomes, composed of DNA, can be decorated with methylation marks that control which genes are turned on and off. Amazingly, the pattern of these markers forms a sort of “code”. “Aging Clocks” are models fit to these DNA methylation patterns. Using them, you can predict someones chronological age, like counting tree rings! This discovery has ushered in a new “Epigenetic Theory of Aging”, and hinted at future therapies for reprogramming cells into a more youthful state.</p><p>RNA is also methylated in several different ways. While DNA methylation has been shown to regulate how genes are transcribed, RNA methylation regulates how those gene transcripts are translated to proteins. Obesity and diabetes, two “diseases of aging”, have deep genetic links to RNA methylation pathways.</p><p>It would be cool if we could connect metabolic syndrome, and its associated diseases of old age, with “aging” itself. Caloric restriction, and then later methionine restriction, have left us important clues here that hacking metabolism can extend lifespan. Similarly, drug interventions like rapamycin, that affect protein sensing via mTOR, can also extend lifespan! Given that we cannot synthesize methionine, and that methionine is the ultimate source of the methylations in our DNA and RNA, could this hint that all of these pathways are linked?</p><p>Wouldn’t it be neat if DNA methylation and RNA methylation were linked? If aging clocks are correct, then the “methionine code” within our DNA must have some way of knowing how much time has passed. Cells have been shown to have <a href="https://en.wikipedia.org/wiki/Circadian_clock">internal circadian clocks</a>, that can track time over a day, but extending this timekeeping to a human lifetime is quite a feat! The DNA molecule, all by itself, cannot keep time. The methylation patterns on DNA must be “written” by the cell in a manner that reflects the passage of time. Finding these external processes, and their link to either age, or a process of “aging” is what we must decipher. Wouldn’t it be neat if these two “methionine codes” could pass information between each other?</p><h3>DNA and RNA methylation are Interlinked!</h3><p>Just 8 months ago, as I write this, a <a href="https://pubmed.ncbi.nlm.nih.gov/36071173/">fascinating paper was published in Nature Genetics</a> that found a mechanistic link between DNA methylation and RNA methylation. The paper is extremely dense, as they had to go to incredible lengths to establish what is a fairly complex process, but the summary is that they found a mechanism by which RNA m6A markers can drive the de-methylation of DNA CpG sites!</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/862/0*dXBBzt2eN4hY5Uye.png" /><figcaption>Figure from the paper : <a href="https://pubmed.ncbi.nlm.nih.gov/36071173/">https://pubmed.ncbi.nlm.nih.gov/36071173/</a></figcaption></figure><p>The paper begins with a discussion of a bioinformatics analysis that they performed on existing RNA and DNA methylation datasets. They found that for a large fraction of genetic loci, CpG methylation sites in the DNA tend to occur near (within 2kilobase) regions of m6A methylation in the RNA transcripts, although they also found that the level of these methylations are negatively correlated in 2/3 of all loci. It is important to recognize that this clustering of DNA CpG sites and RNA m6A sites are found on a per-gene basis. If this pattern is real, understanding these gene sets may be critical to better understand which cellular pathways are regulated by this mechanism.</p><h3>Time to knockdown some genes!</h3><p>With this bioinformatic analysis suggesting that RNA and DNA methylation may influence eachother, the authors then went about knocking down important genes to see what methylation patterns could be modified. The focused on genes that partake in both the writing and erasing of m6A markers. (See below)</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*G2hFvGu85xWf-61J.png" /><figcaption>Figure from this excellent review here : <a href="https://www.mdpi.com/2073-4425/12/7/1019">https://www.mdpi.com/2073-4425/12/7/1019</a></figcaption></figure><p>As discussed previously, RNA methylation markers are created by a “writer” complex that forms at the site of DNA transcription. The METTL3 and METTL14 genes are critical components of this complex, so the authors knocked these down to observe the effects. When METTL3 is knocked down, they found that the vast majority of RNA methylation sites decreased, as can be expected. Intriguingly however, this knockdown of an RNA methyltransferase also changed DNA methylation levels, with a large proportion of DNA methylation sites <em>increasing</em>.</p><p>They also knocked out METTL14, another key component of the writer complex, and assessed global DNA methylation levels in three different cell lines. In each experiment, global DNA methylation increased by about twofold. They then knocked out the <strong>FTO</strong> gene, which recall is an RNA m6A “eraser” gene and is also the most important genetic factor behind obesity. With FTO knocked out, global DNA methylation levels fell! That is, this RNA demethylase appears to be regulating the DNA epigenome!</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/737/0*F8lHFgzdj41UcNKH.png" /><figcaption>Figure taken from the paper : <a href="https://www.nature.com/articles/s41588-022-01173-1">https://www.nature.com/articles/s41588-022-01173-1</a></figcaption></figure><p>This is truly amazing! These knockdown experiments messed with genes that write or erase RNA methylation markers, yet they had profound effects on DNA methylation patterns! This strongly hints that RNA methylation markers are effectively “talking back” to the genome! Perhaps a feedback mechanism!</p><h3>Finding the Machinery</h3><p>The authors set out to discover how this RNA -&gt; DNA communication is taking place, and through a set of thorough experiments, have come up with the following model. When DNA is transcribed into RNA, the m6A methylation markers can be written right at the site of that genes location in the genome.</p><p>Several proteins are known to bind to these m6A markers, and one in particular is FXR1. That protein, in turn, can bind to the TET1 protein, which just so happens to be the “eraser”of DNA methylation markers!</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/817/0*zogz63_4Ya_LAhV0.png" /><figcaption>Figure taken from the paper : <a href="https://www.nature.com/articles/s41588-022-01173-1">https://www.nature.com/articles/s41588-022-01173-1</a></figcaption></figure><p>Importantly, since this is all happening locally at the site of transcription, we have a situation where a gene’s RNA transcript is primarily influencing the local DNA methylation patterns associated with that same gene in the genome. Put another way, the central dogma is running backwards here!</p><h3>Hypothesis : Nutrient Sensing and Genetic “Feedback”</h3><p><strong>Speculation zone: </strong>It’s generally accepted that cells must precisely control the amount of each protein in the cell, and there is clearly many layers to this. DNA must be unwound correctly, at the right time, and the right locations in the genome for each cell type in the body. Transcript levels must be tightly regulated, for each gene uniquely, and their passage to protein translation must similarly be tightly regulated. All of these dynamics are further affected by nutrient availability, which could potentially change rapidly during times of starvation or stress. In all of these circumstances, each gene must be independently fine-tuned. Global regulatory processes are in play, but also feedback mechanisms at the single-gene level.</p><p>So what’s going on here? Why is it that, for a large fraction of genes, high levels of RNA methylation promote DNA demethylation at the site of that genes locus within the DNA? One hypothesis is that each gene in our genome can keep its own internal record-keeping of available cellular methionine, which is the critical first amino acid of every synthesized protein. During times of methionine abundance, higher cellular levels of S-adenosyl-methionine (SAM) could result in higher levels of RNA m6A methylation for a specific gene that is undergoing active transcription. Once formed, m6A sites recruit TET1 to that specific genes’ locus within the genome to demethylate it, making it more likely to be further transcribed. During times of methionine starvation, no recruitment would occur, potentially leaving the methylation levels of that locus unchanged, in the near term.</p><p>In short, this is all just speculation, but this RNA-&gt;DNA methylation pathway may be a gene-specific feedback mechanism by which nutrient abundance is recorded. The fact that the obesity gene FTO counteracts these m6A markers is intriguing, especially since the authors of the last paper demonstrated that FTO knockout can globally reduce DNA methylation levels. Given the strong evidence we have that methionine restriction can extend an organisms lifespan, it is possible that DNA methylation is being reprogrammed precisely through this nutrient sensing pathway.</p><h3>The Future — Where do we go from here ?</h3><h3>Promising supplements</h3><p>While writing this long blog post, it became clear to me that this topic needed its own unified section. There are two key supplements that have been investigated for their longevity-promoting effects, and both directly tie to these pathways Ive discussed.</p><h4>Alpha Ketoglutarate (AKG)</h4><p>In recent years, awesome work by Gordon Lithgow, Brian Kennedy, and many others, <a href="https://www.buckinstitute.org/news/a-metabolite-produced-by-the-body-increases-lifespan-and-dramatically-compresses-late-life-morbidity-in-mice/">has shown that this molecule has lifespan-extending properties</a> in model organisms. The average lifespan increase in mice was a modest %12, but they noticed a more prominent effect on overall health. They argue that, since AKG decreases with age, it may be a promising dietary intervention.</p><p>Watch this <a href="https://www.youtube.com/watch?v=_vh8LeQNA_U">excellent review from Sheekey Science</a> about these particular longevity experiments.</p><p>Alpha ketoglutarate is a fascinating metabolite. As mentioned previously, it is a required cofactor for the FTO obesity gene. It is also the required cofactor for the DNA demethylase TET1, as well as the cofactor needed to demethylate histones. If you want to demethylate DNA, RNA, or histone proteins, the cell needs alpha ketoglutarate!</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/272/0*DJg4Go_ZsHfCz2rn.png" /></figure><p>Alpha ketoglutarate is one of the key steps in the krebs cycle, the set of key reactions in our mitochondria that produces most of our cellular energy. Most interestingly however, AKG is right in the center of two key control points of the TCA cycle. It is formed by Isocitrate dehydrogenase, an enzyme that is inhibited by high ATP concentrations. Immediately after AKG in the Krebs cycle is the Alpha Ketoglutarate Dehydrogenase complex, which converts AKG to Succinyl-COA. It too is inhibited by ATP. Because the AKG metabolite finds itself in this key regulatory node in the cycle, it is <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703346/">potentially a sensor for metabolic state</a> by the enzymes that rely on it as a cofactor. Additional studies <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169906/">point to evidence that it is a sensor of redox stress</a>.</p><p>The obesity connections to AKG, and the longevity benefits of AKG in model organisms, is a hint that this pathway must be further scrutinized.</p><h4>S-Adenosyl-Homocysteine (SAH)</h4><p>An <a href="https://pubmed.ncbi.nlm.nih.gov/35388610/">intriguing paper</a> shows that the metabolite S-Adenosyl-Homocysteine has lifespan-extending effects in both yeast and c-elegans roundworms. The paper presents the central thesis that these effects are mediated through the same pathways by which methionine restriction works. They point to evidence suggesting AMPK activation as a key cause of the effects.</p><p>S-adenosyl-homocysteine is interesting to me because it is the byproduct of the methylation reactions that modify both DNA and RNA. It is effectively formed when the “methyl” is removed from S-adenosyl-methionine. SAH is what remains.</p><p>When SAH levels are high, they can actually inhibit the methyltransferase enzymes that produce it. It has been <a href="http://s-adenosyl-homocysteine/">specifically shown to inhibit the METTL3 enzyme that is the core of the m6A</a> writer complex that methylates RNA. Unsurprisingly, SAH also inhibits the DNA methyltransferase DNMT1, which writes the CpG sites to the genome. <a href="https://pubmed.ncbi.nlm.nih.gov/19362833/">Drugs are being developed that are analogues of SAH</a> for anti-cancer use. Time will tell if pharmacological targeting of this pathway could potentially effect aging as well!</p><h3>Promising Dietary Interventions</h3><p>I’ve already discussed methionine restriction here as a potent intervention that is now demonstrated in several animal models. The easiest way to achieve this is to stick with specific plant-based foods. As time goes on, I would not be surprised if low-methionine recipes become as common as other popular dietary restrictions.</p><p><a href="https://ar.iiarjournals.org/content/42/2/641">Methionine restricted diets are being experimented with</a> in cancer treatment. Given the optimistic data that<a href="https://www.fondazionevalterlongo.org/en/professor-longos-new-book-fasting-cancer/"> Valter Longo has collected</a> showing that fasting can help with cancer survival, I would not be surprised if CR and methionine restriction both become the standard of cancer care. If these strategies are proven effective, low-methionine hospital meals would be commoditized and more accessible.</p><p>When the low-fat craze took hold to fight heart disease, we engineered our food in creative ways. Engineering methionine out might be the next big achievement of the food industry.</p><h3>Desired Pharmacological Targets</h3><p>Given that FTO is 1) the dominant gene in obesity, and 2) apparently regulates DNA methylation indirectly via the RNA-&gt;DNA feedback pathway, it is clearly an important target for future drug development. Time will tell, but if we ever successfully target it to treat obesity, it would be amazing if it also had anti-aging properties as well. Time will tell.</p><p>Knocking out FTO completely is embryonically lethal, and over-expressing it has promoted weight gain in lab animals via increased food intake. It is clear that its expression must be precisely controlled for proper development. Despite this, I’m optimistic that it can be potentially targeted with drugs after development, particularly during later life.</p><p>Excitingly, <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496078/">FTO inhibitors have recently been developed as cancer</a> therapeutics. The next few years may be exciting if new experiments find metabolic or anti-aging benefits to these compounds. Buckle up.</p><h3>Experiments Needed!</h3><p>While diving deep into these pathways has allowed me to connect a few dots I’ve been thinking about for more than a decade, it has also created more questions than it answered. Many experiments are needed to properly develop this theory further.</p><p>First and foremost, we need more studies that assess the Aging Clock on organisms that have undergone caloric restriction and methionine restriction. Ive attempted to find clear studies that have shown this, but the results haven’t been clear. The most appropriate way to conduct this study would be to measure the aging clock in multiple organs, <em>especially the hypothalamus</em> where the key nutrient sensing neurons are located. Several have postulated that hypothalamic aging may be the central regulator of organismal aging, and I fall firmly within that camp given my focus on obesity physiology.</p><h3>Conclusion</h3><p>Taking this deep dive has given me much excitement for the future of anti-aging therapies. Ive focused my career on obesity for personal reasons, but have always been fascinating by aging. I think some of these pathways point to underlying connections. The advent of DNA clocks has given me a refreshingly optimistic look for the future of the field.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/100/0*7eBiGhSHX5U0VrB0" /></figure><p><em>Originally published at </em><a href="https://blog.infino.me/the-methionine-code/"><em>https://blog.infino.me</em></a><em> on June 3, 2023.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=3f6364e4657c" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[How you can help fight COVID-19]]></title>
            <link>https://medium.com/@InfinoMe/how-you-can-help-fight-covid-19-2bfbbc883eb6?source=rss-35f9b5de680f------2</link>
            <guid isPermaLink="false">https://medium.com/p/2bfbbc883eb6</guid>
            <category><![CDATA[covid-19-treatment]]></category>
            <category><![CDATA[antivirals]]></category>
            <category><![CDATA[covid19]]></category>
            <category><![CDATA[coronavirus]]></category>
            <category><![CDATA[folding-at-home]]></category>
            <dc:creator><![CDATA[infinome]]></dc:creator>
            <pubDate>Thu, 16 Apr 2020 17:57:53 GMT</pubDate>
            <atom:updated>2020-05-17T18:45:16.100Z</atom:updated>
            <content:encoded><![CDATA[<p>Covid-19 is clearly one of the most significant health crises of modern times, and our nonprofit is trying to contribute to the fight as much as we can. We need your help though! YOU can join the fight alongside us.</p><h3>Donate your computer to find COVID-19 drugs!</h3><h4>Join Quarantine@Home!</h4><p>Last month we very quickly build Quarantine@Home, a <a href="https://github.com/cjmielke/quarantineAtHome">completely open-source</a> software package that simulates small-molecule drug binding to COVID-19 proteins. We are one of the winners of the <a href="https://devpost.com/software/quarantine-home">Coronavirus Global Hackathon</a>. Since then, we have amassed <a href="https://quarantine.infino.me/users/">about 50 volunteers</a> who have collectively simulated ~250,000 (and growing) drugs. <a href="https://quarantine.infino.me/">You can see the results here</a>. WE NEED MORE VOLUNTEERS. Despite computing 250k calculations already, there are nearly <a href="http://zinc.docking.org/">1-billion possible drugs in the database</a>.</p><p>To join : <a href="https://cjmielke.github.io/quarantine-files/releases/quarantineInstall.exe">Windows</a>, <a href="https://cjmielke.github.io/quarantine-files/releases/QuarantineAtHome.dmg">Macintosh</a>, and <a href="https://quarantine.infino.me/">Linux</a> clients are all available!</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/951/0*wtY1_9Js-wORRLcL.png" /></figure><h4>Join Folding@Home!</h4><p>After we rolled out Quarantine@Home, we found out that <a href="https://foldingathome.org/2020/03/30/covid-19-free-energy-calculations/">Folding@Home very quickly retrofitted their platform to perform “Free Energy Perturbations” (FEP)</a> to simulate drugs bound to coronavirus proteins. This is an impressive upgrade to their network, which primarily has been used to simulate proteins “folding” by themselves. We’re now collaborating with Folding@Home, as their simulations need docked poses to begin with. We are hoping to use the docking algorithms (based on <a href="http://autodock.scripps.edu/">Autodock</a> developed by <a href="https://www.scripps.edu/">Scripps Research</a>) to pre-screen from the billion possible drugs, and <a href="https://twitter.com/jchodera/status/1248316119976251393">Folding@Home can perform much more comprehensive simulations</a> of the best binders.</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2FRtB612XzWrg%3Ffeature%3Doembed&amp;display_name=YouTube&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DRtB612XzWrg&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2FRtB612XzWrg%2Fhqdefault.jpg&amp;key=a19fcc184b9711e1b4764040d3dc5c07&amp;type=text%2Fhtml&amp;schema=youtube" width="640" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/a3b8d6b0700397fde2ee1d792efcf8e7/href">https://medium.com/media/a3b8d6b0700397fde2ee1d792efcf8e7/href</a></iframe><p>Free Energy Perturbation performed by the <a href="http://www.choderalab.org/">Chodera Lab </a>for Folding@Home!</p><p><a href="https://foldingathome.org/">You can join Folding@Home at this page</a>.</p><h4>About the author</h4><p><a href="https://twitter.com/subC0smos">Cosmo is a PhD computational scientist</a> working at the University of California, San Francisco. In his spare time he runs Infino.Me, a nonprofit dedicated to curing disease with citizen science.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/100/0*FKzq8fxel0F-NvC0" /></figure><p><em>Originally published at </em><a href="https://blog.infino.me/how-you-can-help-fight-covid-19/"><em>https://blog.infino.me</em></a><em> on April 16, 2020.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=2bfbbc883eb6" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Osteopontin : Building Skeletons in Aging’s Closet]]></title>
            <link>https://medium.com/@InfinoMe/osteopontin-building-skeletons-in-agings-closet-62fee778ddca?source=rss-35f9b5de680f------2</link>
            <guid isPermaLink="false">https://medium.com/p/62fee778ddca</guid>
            <category><![CDATA[health]]></category>
            <dc:creator><![CDATA[infinome]]></dc:creator>
            <pubDate>Sun, 17 Mar 2019 00:24:33 GMT</pubDate>
            <atom:updated>2019-03-29T22:35:43.217Z</atom:updated>
            <content:encoded><![CDATA[<h3>Osteopontin : Building Skeletons in Aging’s Closet</h3><p>It’s high time I finally get around to telling you about my favorite protein, one that I originally stumbled upon in my Diabetes PhD at ASU and the Mayo Clinic over 6 years ago. Ever since, I have been slowly deciphering what exactly is going on. <a href="https://repository.asu.edu/attachments/114525/content/Mielke_asu_0010E_13262.pdf">I’ll be summarizing some parts of my dissertation</a>, so this might be a long one, but its worth it….</p><p>At the Mayo Clinic, <a href="https://blog.infino.me/how-does-exercise-change-muscle/">we performed a rather lovely experiment where we obtained glucose clamp data on test subjects, and coupled this with gene expression analysis on muscle biopsies before and after exercise</a>. This work resulted in a great deal of interesting hits, including the pathway I’m going to discuss today.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/568/0*nu1ZVQNsjJWlQSkZ.png" /></figure><p>From that study, we were able to obtain a list of genes that change with exercise in a manner that strongly correlated with insulin sensitivity before exercise. Among the positive correlates was the gene ACP5. For whatever reason, insulin sensitive subjects made more ACP5 post exercise than the insulin resistant (diabetic) subjects.</p><p>The ACP5 gene is more commonly named <a href="https://ghr.nlm.nih.gov/gene/ACP5">TRAP (Tartrate Resistant Acid Phosphatase)</a>. It enzymatically removes phosphate groups from proteins, but the immediate question is, could it have something to do with metabolic syndrome? The first profound clue that it does was a study I found that over-expressed this gene in mice, and the result is glaringly obvious. Turn TRAP on, and mice get <strong>GINORMOUS</strong>, but more importantly, they remain <strong>completely insulin sensitive</strong>. IE, they get fat, but not diabetic. WTF? Even more interesting, there are some profound sex differences in this effect, particularly with food intake. Sorry ladies.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/574/0*hmdaa6y0dDuE_NPJ.jpg" /></figure><p>So what’s going on here? Years ago I began digging for a mechanism of action, and I learned that in bone, TRAP/ACP5 has a well-characterized function. It’s an important molecule that regulates the attachment of cells that create and destroy bone, the osteoblasts and osteoclasts.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/691/0*Van6Ak10obgF3Lq_.jpg" /></figure><p>Osteoblasts bind to bone and lay down minerals, while osteoclasts (figure above) bind to bone and secrete acids into a controlled space to dissolve the bone matrix. Among the many things secreted into this space is the ACP5/TRAP protein. To keep the acids contained in the pocket, the cells form a “sealing zone” around the perimeter with the <a href="https://en.wikipedia.org/wiki/Alpha-v_beta-3">αVβ3 integrin receptor</a>, also known as the <a href="https://en.wikipedia.org/wiki/Vitronectin">vitronectin</a> receptor. This receptor binds to, naturally, the protein known as <a href="https://en.wikipedia.org/wiki/Vitronectin">vitronectin in the bone extracellular matrix</a>. It has a few other binding partners however, and one of them is a little gene called <a href="https://en.wikipedia.org/wiki/Osteopontin">SPP1, also known as bone sialoprotein 1, and <strong>osteopontin</strong></a>.</p><p>Osteopontin is evidently one of the core regulators of osteoclast binding to bone due to its binding to the αVβ3 receptor, but also appears to mediate the detachment process. In 1994, <a href="https://www.ncbi.nlm.nih.gov/pubmed/8195113">it was shown that attachment was dependent on osteopontin phosphorylation. The TRAP enzyme pops this phosphate off of osteopontin</a>, and when this happens, the osteoclast can release from the bone.</p><p>So the ACP5/TRAP gene, which is strongly associated with insulin sensitivity when it’s activated after exercise, dephosphorylates proteins. Osteopontin is one of them. Who cares?</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/633/0*TgE-rE-6ULpysqyh.jpg" /></figure><p>Aside from bone stuff, what else is osteopontin involved with? Well, <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2980483/">scientists decided to go create another franken-mouse.</a> This time, they knocked the osteopontin gene out of the genome to see what happened. What they found was spectacular. These mice were <strong>completely protected from a high fat diet.</strong></p><p>If you feed a normal mouse a high fat diet, they develop insulin resistance and all of the symptoms we associate with diabetes. Remove osteopontin from the animal, and a high fat diet barely produces any change in insulin sensitivity. No diabetes symptoms!</p><p><strong>WAT WAT WAT?</strong> (that’s a white-adipose-tissue joke)</p><p>In summary, turn on TRAP expression in a mouse, and they get super insulin sensitive. TRAP dephosphorylates osteopontin. If you knock osteopontin out of a mouse, they never get insulin resistant. We also know that osteopontin phosphorylation allows it to bind to the αVβ3 receptor in bone, but only if its phosphorylated. TRAP removes this modification. Could this mechanism have something to do with insulin resistance?</p><h3>Enter the immune system</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/492/0*f7VakohtBo_iTQKg.png" /></figure><p>Turns out, osteoclasts come from the same line of cells as macrophages, those lovely-but-crazy cells in our body that eat things that they really don’t like. You really want these guys on your side. They can eat bacteria and other pathogens, but they can also eat cholesterol particles, leading to blockage of blood vessels. Understanding the appetite of these immune cells is thus critical for understanding the leading cause of death.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/574/0*KfH2nPoHNgFrb4Wk" /></figure><p>Macrophages can be “activated” into two different states relevant to their police-like activities. There is an M1 (proinflammatory) state that is associated with the secretion of pro-inflammatory cytokines like TNF-alpha, and there is an M2 “calm the fuck down” <a href="https://en.wikipedia.org/wiki/Macrophage_polarization">state associated with wound repair</a>. The M1 state can be easily induced when the macrophages sense bacterial toxins like LPS. I like to think of this M1 state as police arriving on scene with guns drawn to neutralize an invader, whereas the M2 state is the following investigation, medical, and cleanup crews sent in to heal and repair tissues (like after exercise!).</p><p>Macrophages, and their polarization state, have a direct connection with insulin resistance. <a href="https://www.ncbi.nlm.nih.gov/pubmed/20148674">Jerrold Olefsky at UCSD has long argued that in fact, macrophages invading muscle, fat, and liver</a> tissue are a central component of diabetes.</p><p>As a matter of fact, <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2692398/">it has even been directly demonstrated</a> that the amount of macrophages invading into muscle tissue correlates strongly with body mass index, and that <a href="http://diabetes.diabetesjournals.org/content/62/6/1843">insulin sensitivity can be restored in humans when specific drugs are used</a>, which drive away the invading macrophages out of fat tissues.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/456/0*iOhhpyTSXqkIEBev.jpg" /></figure><p>So, why is it that these macrophages invade these tissues, get polarized into the trigger-happy M1 proinflammatory state, and start shooting? Well, turns out <a href="https://academic.oup.com/endo/article/152/6/2219/2457302">osteopontin is the gene</a> that called in reinforcements. In adipose tissue at least, it directly regulates the inflammatory state of macrophages, and it <a href="https://academic.oup.com/endo/article/152/6/2219/2457302">is generally upregulated in the fat tissue of obese humans</a>.</p><p>Even more exciting, it was later shown that it’s <a href="https://www.ncbi.nlm.nih.gov/pubmed/12377945">specifically osteopontin binding to integrin receptors found in macrophages that regulate their inflammatory state</a>! In this profoundly amazing work, they demonstrated that simply dephosphorlylating osteopontin switches the macrphages into a calmer state, associated with reduced secretion of tumor necrosis alpha (TNF-alpha), which is one of the most potent inducers of insulin resistance in peripheral tissues.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*bNKAqPncIEi3xe8X" /></figure><p>The mechanism at this point appears to be that macrophages are getting recruited into various tissues and triggered into a panic phase. They then secrete proinflammatory cytokines that tell muscle, fat, and liver tissue to become insulin resistant. This happens via the TNF-alpha receptors, and is well characterized. Knock osteopontin out, and mice won’t develop insulin resistance no matter how much fat you feed them. If you instead overexpress TRAP which dephosphorylates osteopontin, mice become completely insulin sensitive. (although fat, because the fat cells are no longer being told to stop taking in glucose…..)</p><h3>Implications for Exercise</h3><p>Let’s circle around to the start of this deep-dive. People who are highly insulin sensitive before an exercise intervention, apparently turn this gene on more after exercise than people who are insulin resistant. The mouse overexpression studies seem to indicate that having abundant levels of this gene promotes insulin sensitivity. It is also known that exercise causes a temporary cessation of insulin resistance, which makes sense from the simple perspective of thermodynamics. After all, the muscle needs to replenish the energy it expended.</p><p>However, could it be that this core pathway represents an anti-inflammatory benefit to exercise? Could this anti-inflammatory effect be present in some, but not all people?</p><h4>Future directions</h4><p>This is the part where I drop the mic with some random factoids about heart disease, which kills 25% of us. I still need to get around to elaborating on these pathways. In doing so, you will be compelled to “stay tuned” for the next post, and I will be compelled to actually write it.</p><p>You can probably see where this is going. I previously argued that <a href="https://blog.infino.me/cholesterol-have-we-shot-the-messenger/">LDL particles can carry viruses around</a>, and this is likely why macrophages eat them in the first place. It should therefore not shock you to <a href="https://www.ncbi.nlm.nih.gov/pubmed/10657301">learn that it is a key mediator in defending against infections from herpes viruses</a>, which are now implicated in heart disease and Alzheimer’s. With the <a href="https://www.pnas.org/content/107/51/22260?fbclid=IwAR3uUolGV1-mx1iGO7O7Q5y1l-tKqSAuXcmxqtRgy-JFa_g-ubL6giUt2BA">vitronectin receptor present, herpes viruses can enter cells through the lipid domains associated with cholesterol import</a>.</p><p>On the aging biology side, some labs <a href="https://www.ahajournals.org/doi/pdf/10.1161/ATVBAHA.116.307839">consider oseopontin</a> to be a <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787458/">key member</a> of the Senescence Associated Secretory Phenotype (SASP). I previously argued that <a href="https://blog.infino.me/could-aging-be-an-infectious-disease/">cellular senescence might in fact be primarily driven by viral infections</a>, and also discussed how the <a href="https://blog.infino.me/cholesterol-have-we-shot-the-messenger/#gm1">senescence associated beta galactosidase</a> may in fact be an antiviral defense mechanism because it specifically cleaves sialic acid residues off of GM1 lipids. These sialic acids are important targets for many viruses, especially influenza. Osteopontin is also known as “bone sialoprotein 1” because it has an incredible <a href="https://en.wikipedia.org/wiki/Osteopontin#Role_in_muscle_disease_and_injury">10 sialic acid residues on it</a>. Because of this, <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579611/">osteopontin has a rather important role as a decoy for viruses to bind to</a>……</p><p><em>Originally published at </em><a href="https://blog.infino.me/osteopontin-building-skeletons-in-agings-closet/"><em>blog.infino.me</em></a><em> on March 17, 2019.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=62fee778ddca" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[How does skeletal muscle change after exercise?]]></title>
            <link>https://medium.com/@InfinoMe/how-does-skeletal-muscle-change-after-exercise-22660b86708b?source=rss-35f9b5de680f------2</link>
            <guid isPermaLink="false">https://medium.com/p/22660b86708b</guid>
            <category><![CDATA[health]]></category>
            <dc:creator><![CDATA[infinome]]></dc:creator>
            <pubDate>Sat, 16 Mar 2019 18:32:58 GMT</pubDate>
            <atom:updated>2019-03-17T02:10:38.970Z</atom:updated>
            <content:encoded><![CDATA[<p>Back at the Mayo Clinic in Scottsdale, our primary research interests were studying insulin resistance in skeletal muscle. In healthy individuals, muscle is expected to take up the majority of glucose after a meal, and this process is driven by the hormone insulin. In type 2 diabetes, the insulin hormone is elevated, but the muscles ignore it. Our job is to figure out why.</p><p>While measuring the bloods glucose level is a useful metric, it’s not a terribly quantifiable measurement for how effective insulin signaling is working. Instead, we use a technique called a hyperinsulinemic euglycemic clamp, which was perfected in the lab of my <a href="https://uahs.arizona.edu/leadership-team/lawrence-j-mandarino-phd">PhD advisors</a> PhD advisor….. <a href="https://www.uthscsa.edu/patient-care/physicians/providers/1851408843/Ralph-DeFronzo">Ralph DeFronzo</a>, making him my scientific granddaddy 🙂</p><p>So here’s what we do. At the start of the experiment, we inject insulin into the test subject at high dose, which tells all peripheral tissues in the body to take up excess blood glucose. We then closely monitor the patients blood glucose, and if it dips below a setpoint, we infuse glucose to compensate exactly, maintaining the blood glucose at a level of 100 μU/ml for a lengthy period of time. At the end of the experiment, we know how much glucose has been infused, and since the blood glucose level is the same, we also know exactly how much glucose has been absorbed.</p><p>The glucose infusion rate must equal the glucose disposal rate. Furthermore, we can divide the glucose disposal rate by the estimated weight of skeletal muscle in the subject, giving us the “M value”, which has units of mg glucose / (min * kg of lean muscle).</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/833/0*ojaahXeuTmrbS6N0.png" /></figure><p>At the Mayo, we would perform these experiments, but also take a <a href="https://en.wikipedia.org/wiki/Skittles_(confectionery)">small-sized</a> muscle biopsy out of one leg. Several days later, we would make the test subjects exercise on a stationary bike, and then take a muscle biopsy out of their other leg….. FUN</p><p>And what can you do with these small hunks of human legmeat? Well, we homogenize them in an overpriced laboratory blending instrument to make a nice liquid muscle goop, and then measure the proteins in that muscle goop. We can also determine which genes are turned on and off, which is known as gene expression analysis. We can do this to determine which genes are activated before exercise, after exercise, and also which genes <strong>changed the most</strong> after exercise, which tells us a great deal. Typically, when these studies are done, statisticians focus on the biggest changing genes, which tend to be high-abundance metabolic enzymes in the mitochondria.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/830/0*I0c4ZmlJ3Td1XLpI.png" /></figure><p>I had a different idea though. Instead of looking for the most statistically significant changers, I looked for genes that correlate strongly with external biomarkers of the subject, like glucose disposal rate (M value described above) and body mass index. When I ran these correlations, I found a number of low-abundance signaling molecules that <strong>barely change</strong> after exercise but <strong>correlate strongly</strong> with these external phenotypes. When digging into the functions of these genes, I found a great deal of signaling pathways that track diabetes genomics.</p><p>In fact, I found so many interesting genes, that I’ve decided to make the description of this experiment its own separate blog entry, and in subsequent blog entries, I will describe single genes of interest and the pathways that they encapsulate. For those of you who are impatient for the laypersons explanation of everything, my dissertation is a deep dive.</p><p>Even better, this <a href="https://docs.google.com/presentation/d/1k9BSaVC3501G_oFunGoZdKJvLS_4yZWryaliHukyZ98/edit?usp=sharing">link will allow you to see my original PhD defense slides online</a>, with graphical descriptions of all of these pathways.</p><h4>Correlations of gene expression with glucose disposal rate, before exercise</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/645/0*6t01pyupArbKzLrk.png" /></figure><p>If we just take the gene expression patterns of muscle, before any exercise intervention, and correlate them with insulin-stimulated glucose uptake rates, we get some neat postitively-correlating genes in the WNT signaling axis, which are the <a href="https://blog.infino.me/bpa/">upstream components that activate the TCF7L2 transcription factor that I described in my writeup on BPA</a>.</p><p>At the bottom of the list, we have negatively correlating genes with glucose uptake. When these genes are activated in muscle, the subject is insulin resistant. These genes largely make up the pathways responsible for muscle protein breakdown, starvation signals, and the inflammatory NFKB pathway that activate these atrophy and muscle-wasting pathways.</p><h3>Correlations of exercised-induced gene expression changes with glucose disposal rate</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/569/0*fCkk-ys4CNUh_D3e.png" /></figure><p>In this table of correlations, we ask the question of which genes change with exercise in a matter that best correlates with the subjects insulin sensitivity. The most exciting hit is ACP5, which was a clue that lead to a great deal of findings for me.</p><p>And of course, the estrogen receptor, ESR1, which <a href="https://blog.infino.me/bpa/">BPA binds to and somehow impacts TCF7L2 signaling</a> 🙂</p><h3>Just for fun, gene expression patterns that correlate with BMI</h3><p>&lt;coming soon&gt; ….. neat stuff be coming …..!</p><p><em>Originally published at </em><a href="https://blog.infino.me/how-does-exercise-change-muscle/"><em>blog.infino.me</em></a><em> on March 16, 2019.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=22660b86708b" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Did Petrochemicals Cause the Diabetes Epidemic?]]></title>
            <link>https://medium.com/@InfinoMe/diabetes-time-to-resort-to-plastic-measures-500cdf1fe528?source=rss-35f9b5de680f------2</link>
            <guid isPermaLink="false">https://medium.com/p/500cdf1fe528</guid>
            <category><![CDATA[health]]></category>
            <category><![CDATA[toxic-chemicals]]></category>
            <category><![CDATA[diabetes]]></category>
            <category><![CDATA[genetics]]></category>
            <category><![CDATA[weight-loss]]></category>
            <dc:creator><![CDATA[infinome]]></dc:creator>
            <pubDate>Wed, 15 Aug 2018 00:12:00 GMT</pubDate>
            <atom:updated>2019-02-24T22:18:56.626Z</atom:updated>
            <content:encoded><![CDATA[<h4>Note : I’ve decided to move this content to a new dedicated blog site :</h4><p>Visit it here : <a href="http://www.blog.infino.me/BPA/">www.blog.infino.me</a></p><p>A Direct Link Between a Common Household Chemical and the <strong>TOP</strong> gene associated with Type 2 Diabetes Warrants investigation.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/799/1*B_gH6B11IuD_NjfNdWGvCQ.png" /><figcaption>The molecule Bisphenol-A (BPA, yellow color) shown in the binding pocket of the Estrogen Receptor gene, overlayed on top of the natural Estrogen hormone molecule (teal). BPA mimics the same shape as Estrogen, but can interfere with the receptor signaling, promoting metabolic abnormalities.</figcaption></figure><p>For the last several years, <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086728/">a small minority of researchers have been sounding the alarm about BPA, a molecule used to make plastics</a>. This molecule binds to hormone receptors at the molecular level. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086728/">At the organism level, its been shown that exposure to mice causes insulin resistance, and BPA shows up more often in the urine of diabetics</a>.</p><p>Today, we are going to dive deep into the genetics of Type 2 Diabetes, and we may find out that the situation is much more dire than we ever considered. It turns out that <strong>BPA</strong> <strong>may be regulating the primary gene associated with Type 2 Diabetes</strong>, found in countless genetic studies. This finding suggests a more subtle and evasive explanation for the diabetes epidemic that we may have ever expected. Our genes haven’t changed in the last 50 years, but the chemicals we make certainly have!</p><h4>I hope you like swimming in data, we are about to dive deep.</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/1000/0*2H_BQmElcWfCKS6s.jpg" /><figcaption><a href="http://thegreentimes.co.za/joburg-school-fills-swimming-pool-with-plastic-to-teach-students-a-lesson/">An excellent way of illustrating this problem</a></figcaption></figure><h3>The Power of Genome Wide Association Studies</h3><p>If you’ve followed <a href="https://medium.com/@InfinoMe/cholesterol-have-we-shot-the-messenger-a3f5dfeba09">my previous two articles, you’ll realize that I’m rather obsessed with genetic association studies</a>. By surveying genetic variants across hundreds of thousands of people, we can figure out the actual molecular mechanisms of disease. The following figure shows us the genetic landscape of Type-2 Diabetes from <a href="https://www.nature.com/articles/ng.609#f1">my favorite meta-analysis</a>. The X-axis indicates the location of a gene in the genome. Points are single-letter changes in that genes code that predispose to the illness. The higher the point, the more significant that single letter change is.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*9ft4bsEdQ7Y7q7LUbENMag.png" /><figcaption>A Manhattan Plot showing the genetic landscape of Type 2 Diabetes from <a href="https://www.nature.com/articles/ng.609#f1">my favorite meta-analysis</a>. Individual points are single genetic variants, and the vertical lines represent the most important genes in the disease.</figcaption></figure><p>We can see that the gene near the middle, TCF7L2, is the most statistically significant predictor, with<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1934573/"> some studies claiming that it roughly doubles your lifetime risk of developing Type 2 Diabetes</a>. In 2015, <a href="http://www.diabetes.org/diabetes-basics/statistics/">9.4% of the US population had diabetes, and over 250,000 people died with diabetes mentioned as a contributing factor. This cost our health system $327 Billion</a> in 2017.</p><p><strong>This is a big deal, and that gene is the center of it all.</strong></p><h3>BUT IT’S NOT ALL GENETICS</h3><p>Yes, that’s true. The genome describes the code running within our bodies, but our lifestyle certainly matters. The FTO gene in that plot above is the top obesity gene, for example. The MTNR1B gene is a melatonin receptor, which regulates how cells in your body respond to sleeping patterns. Common knowledge indicates that diet, exercise, and sleep all matter.</p><p><strong>But are these factors the most important factors?</strong> Could there be something else? Perhaps something that explains that top gene, TCF7L2? All diseases are <strong>both a product of both our genetics and our environment</strong>.</p><h3>Gene’s aren’t static</h3><p>While your genome happily sits in your cells nucleus containing the blueprint for how to build everything in your body, those genes must be turned on in specific tissues, and at specific times, to perform useful work. The activation of genes in your body is called “gene expression”, and patterns of these gene expression can tell us about the specific programs that cells are running.</p><p>Eat something, and metabolic genes are turning on. Fall asleep, and repair genes are turning on. Run from a tiger, and genes are switching on (HOPEFULLY) to build faster muscles. If the wrong genes switch on however, or if important genes switch off, function of a cell can be lost, and disease can result.</p><h3>Drugs change gene expression</h3><p>Exposure of cells to chemical compounds can also change gene expression patterns. This can be bad, in the case of toxins, or good, in the case of drugs.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/293/0*rGKsBbveVfHzsfuW" /><figcaption>A diagram indicating the incredible size of the CMap database</figcaption></figure><p>The <a href="http://broadinstitute.org/">Broad Institute</a>, one of the largest genomic research organizations, has systematically tested gene expression patterns in many different cell types exposed with <strong>more than 19,000 substances</strong>. This large dataset is the <a href="https://clue.io/connectopedia/cmap_overview">Connectivity Map (CMap)</a>. They have made available a fantastic online search tool that <a href="https://clue.io/connectopedia/cmap_overview">exposes the data</a> to exploration from citizen scientists like us!. If you are a nerd like me, you might find yourself digging into the data for months getting lost with the genomes shear complexity.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*DmcabDrjUR1dVQow" /><figcaption>An overview of what the L1000 assay looks like <a href="http://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1005335#pcbi-1005335-g001">from this paper</a></figcaption></figure><p>Fortunately for us citizen scientists, <strong>YOU</strong> can query this data yourself for genes or compounds of interest. This is the interactive portion of this article. <a href="https://clue.io/">FOLLOW THIS LINK RIGHT NOW</a>, and type the command “/conn TCF7L2” to query the database for drugs and genes that “perturb” the top Type-2 Diabetes gene…. TCF7L2</p><p>Seriously, do this. I want you to understand that you shouldn’t trust some random Medium blogger, but this dataset is hosted by one of the most respectable biology research institutions funded on a project run by the NIH. This data is quite real, and it isn’t even mine :D</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/587/1*D-NRllyiR0GApx8TvgGa5w.png" /></figure><p>Out of more than <strong>19,000 compounds</strong> in the database, the heatmap shown will <a href="https://clue.io/connectopedia/connectivity_scores">only include the top positive and negative scoring connections</a>. In general, if a compound has a highly positive score, it means that it causes a shift in gene expression highly similar to the thing you queried for. A negative score implies a shift in the opposite direction.</p><p>After querying for TCF7L2, you should see a screen that looks like this. We’ll mostly discuss the compounds in this article, but it’s worth noting that the top associated gene, CDKN2B, <a href="https://medium.com/@InfinoMe/senescence-links-between-heart-disease-genomics-and-aging-fa78bde773da">was discussed in our previous analysis as the top gene associated with heart disease</a>. <strong>It is also one of the shorter peaks in the T2D Manhattan Plot above</strong>, and so clearly has a genetic link with diabetes.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/885/1*QDIjWFJy1fvArrWPGgknvA.png" /><figcaption><a href="https://clue.io/command?q=/conn%20TCF7L2">Results in CMap for TCF7L2</a>, showing the top connected perturbagens (drugs and gene alterations)</figcaption></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/450/0*g2k8F8Cl1WVrhW3x" /><figcaption>At more than 2 million tons annually, we are still not FREE of BPA</figcaption></figure><p>That compound at the very top of the list, <a href="https://en.wikipedia.org/wiki/Bisphenol_A">bisphenol-a (BPA</a>), is one of the most mass-produced chemicals by man, and is used to make polycarbonate plastic and epoxy resins. It began use in consumer products around 1953. In the 1980s, mankind produced over <a href="https://www.reuters.com/article/us-chemical-bpa-health/experts-demand-european-action-on-plastics-chemical-idUSTRE65L6JN20100622?loomia_ow=t0:s0:a49:g43:r3:c0.084942:b35124310:z0">1 MILLION TONS annually, and that doubled to NEARLY 2.2 MILLION TONS in 2009</a>. While its use is being phased out in many plastic bottles, <a href="https://www.fastcompany.com/1750449/why-coca-cola-isnt-ditching-bpa">to this day, BPA-containing resins still line the inside of every soda can</a>. Incidentally enough, consumption of sugar sweetened beverages, including those from cans, is one of the easiest predictors of diabetes known to the research community. Maybe it wasn’t just the sugar!</p><p><strong>But I don’t drink soda pop!</strong></p><p>Don’t worry: <a href="https://toxtown.nlm.nih.gov/chemicals-and-contaminants/polyvinyl-chloride-pvc">Traces of BPA are also contained in the PVC water pipes that l</a>ikely supply your house, and this is <a href="https://www.sciencedirect.com/science/article/pii/S1438463911000472">thought to be a primary route of exposure</a>. Even more astonishing, BPA is used to coat the paper used to print receipts. Every time you buy a product and take a receipt from the purchase, <a href="https://pubs.acs.org/doi/abs/10.1021/acs.est.7b03093?source=cen">small amounts of BPA pass through the skin and show up in urine for a period of time longer than if it were ingested</a>! Intriguingly, <a href="https://www.ncbi.nlm.nih.gov/pubmed/29778011">its been shown that cashiers, who handle receipts daily, have higher levels of BPA in their urine and a higher prevalence of insulin resistance</a>.</p><p>In our receipt-filled consumer society, this is an ironic example of how the consumption of <strong>anything</strong> can still predispose you to diabetes.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/500/0*oCd7YOBOPBBFNPip.gif" /><figcaption>Figure from a<a href="https://pubs.acs.org/doi/abs/10.1021/acs.est.7b03093?source=cen"> frightening study demonstrating detectable levels of BPA </a>after just a single contact with a receipt.</figcaption></figure><p>As a diabetes geneticist, I can tell you that talks about BPA rarely take center stage at the largest diabetes conferences . This database however indicates that BPA is the strongest compound (out of 19k others in the Broad database!) in perturbing the function of that gene. The Connectivity Map experiments <strong>were not performed with any particular hypothesis in mind</strong>. They simply threw as many chemicals as they could against as many cells as they could.</p><p>What does BPA do, exactly? It disrupts your hormone receptors! It binds to both estrogen receptors, as well as the androgen receptor (AR), which senses the hormone testosterone. Incidentally, the second compound on the list above is <a href="https://en.wikipedia.org/wiki/Androstenedione">Androstenedione</a>, an intermediary byproduct of hormone production in the human body that weakly binds to both receptors as well.</p><p>It gets worse. Recall that TCF7L2 is not the only gene behind Type-2 Diabetes, just the most significant. The second most significant gene is CDKAL1.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*__XWlKtxxdDzOhgJvj0s6g.png" /></figure><p>Plug CDKAL1 into clue.io, and you’ll once again find bisphenol-a in the top-hit list. Its no longer first place, but 5th out of &gt;19,000 other compounds. The top hit is a potassium channel blocker, which is interesting because two potassium channels (KCNJ11 and KCNQ1) are also associated in the plot above.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*VoiZjiY8srC-kePTszDNAw.png" /></figure><h3><strong>How Does BPA Break Us?</strong></h3><p>To understand why BPA leads to diabetes, we need to understand what the TCF7L2 gene is and how it works in the cell. Genes aren’t static in the body, but constantly switched on and off. At the molecular level, this is performed by “Transcription Factor” genes that bind to DNA at very specific locations to activate other downstream genes. Transcription Factors are somewhat like the __main__ methods of specific cellular programs.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/832/0*ylK6vhr-PCrKdlI7.png" /><figcaption>T-cell factor (TCF) proteins bind to DNA and inhibit the adipogenic (fat storing) program of the cell. <a href="https://www.ncbi.nlm.nih.gov/pubmed/21952300">This figure taken from the best darn review of TCF I have ever found</a>.</figcaption></figure><p>TCF7L2 is a member of the TCF family of transcription factors that regulate adipogenic (fat) and myogenic (muscle) growth. It is activated by the WNT (“wint”) signaling genes that bind to “Frizzled” receptors, and the cascade of reactions eventually allows genes like TCF7L2 to bind to DNA and turn other genes on, telling a single cell what kind of cell it should grow up to be.</p><p>It has been shown that this WNT signaling axis is critical for proper development of the pancreas and muscle. <a href="http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008509">In fact, if you turn this signaling pathway off in muscle cells, they start storing fat and acting like fat cells</a>! The loss of muscle protein, and the accumulation of fat inside a muscle cell is a defining feature of Type 2 Diabetes.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*frMMfYfcX51ZLZPTF-CK2w.png" /><figcaption>Figure from <a href="http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008509">this influential paper</a>. Inhibiting this primary signaling pathway in muscle “myotubes” with an inhibitor (BIO) results in the accumulation of lipid droplets (red) in the cell. The nucleus of the cell is blue.</figcaption></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/659/1*kMNdzPKck7Lj1pWM3xGHkA.png" /><figcaption>A <a href="https://en.wikipedia.org/wiki/Western_blot">western blot </a>from <a href="https://www.sciencedirect.com/science/article/pii/S155041311300017X">this paper</a> showing that “knocking down” (not completely) the TCF7L2 gene leads to a <strong>DRAMATIC</strong> loss of Insulin receptors in cells</figcaption></figure><p>TCF7L2, it turns out, is a core activator of <strong>the entire insulin signaling pathway</strong>. In fact, if you turn TCF7L2 off, the insulin receptor itself is turned down, directly limiting the cells uptake of glucose. If this happens, your pancreas can release all the insulin it wants but your tissues will leave the glucose in the blood. This is diabetes in a nutshell. <a href="https://www.sciencedirect.com/science/article/pii/S0009279716306445#undfig1">As it turns out, the molecule <strong>BPA causes a similar decrease in insulin receptors when exposed to muscle</strong></a>, which is further evidence of this direct molecular link.</p><p>Furthermore, even relatively low doses of BPA, <a href="http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0002069">when exposed to pancreatic beta islet cells, will stimulate a substantial release of insulin</a>, which is another hallmark of Diabetes and Obesity. Years of this elevated hormone secretion that yields to eventual death of the beta islet cells. When this “beta cell burnout” occurs, the body fails to produce enough insulin to dispose of blood glucose properly, and the most severe symptoms of the illness take hold. Interestingly enough, <a href="https://www.ncbi.nlm.nih.gov/pubmed/23328667">even small concentrations of BPA have been demonstrated to cause the death of pancreatic cells</a> through this mechanism.</p><p>All in all, this molecule, produced in the millions of tons per year, seems to decrease insulin receptors in cells, increase insulin production in pancreatic cells, and cause eventual death of those pancreatic cells. <strong>These are all the hallmarks we have grown familiar with</strong>.</p><h3>It’s Time for Plastic Measures!</h3><p>The debate over BPA has raged on for a decade, and a central feature of this perpetual debate is regarding whether or not the concentration of BPA used in lab experiments is relevant for levels of environmental exposure. Alongside this debate are numerous industry advocacy groups that espouse the safety of BPA by sponsoring scientific research that greatly discounts the mounting evidence : <a href="https://www.factsaboutbpa.org/bpa-overview/myths-realities">https://www.factsaboutbpa.org/bpa-overview/myths-realities</a></p><p>Despite the aggressive discounting of these industry groups, it has been shown in mice that a <a href="https://www.ncbi.nlm.nih.gov/pubmed/23892310">serum concentration of BPA tenfold beneath safe guidelines during pregnancy can permanently alter the metabolic hormone profiles and insulin sensitivity</a>. Beyond this, <a href="https://www.ncbi.nlm.nih.gov/pubmed/18799442">epidemiological evidence from the NHANES cohort shows a higher risk of cardiometabolic risks in participants with higher urine BPA levels</a>.</p><h4><strong>Genetic Effects</strong></h4><p>A study in <a href="https://academic.oup.com/jcem/article/101/1/143/2806657">2016 it was shown that specifically those with a high genetic risk were most susceptible to developing diabetes with BPA exposure</a>.</p><p><a href="https://academic.oup.com/jcem/article/101/1/143/2806657">Diabetes Genetic Risk Score Modifies Effect of Bisphenol A Exposure on Deterioration in Glucose Metabolism | The Journal of Clinical Endocrinology &amp; Metabolism | Oxford Academic</a></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/613/1*S9RxfRdpssqtjLoKqD-dtg.png" /><figcaption>Figure from this <a href="https://academic.oup.com/jcem/article/101/1/143/2806657">excellent paper assessing the combined effects of genetics and BPA exposure</a> in the development of diabetes.</figcaption></figure><p><strong>So what do we do about this?</strong></p><p>Given this evidence, it is highly possible that BPA is exerting its influence through a mechanism that is highly dependent on which version of the TCF7L2 gene you have. If this precise molecular mechanism can be found, we could potentially study diabetes in a much deeper way. To address this concern, we aim to conduct a citizen science project soon to study the relationship between BPA exposure and disease incidence. If you want to know when we launch this nonprofit project, follow us (<a href="https://medium.com/u/35f9b5de680f">infinome</a> and<a href="https://twitter.com/InfinoMe"> here on Twitter</a>) to hear when we launch new research initiatives.</p><h3>You did it didn’t you? You drank it all up!</h3><p>Could we have done this to ourselves? All this fighting over macronutrients, and it might turn out to be a tiny little molecule, only nanograms of which bind to the wrong receptors at the wrong time?</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*yNLQKMwU769upHcRUArAUg.png" /></figure><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=500cdf1fe528" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Cholesterol: Have we Shot the Messenger?]]></title>
            <link>https://medium.com/@InfinoMe/cholesterol-have-we-shot-the-messenger-a3f5dfeba09?source=rss-35f9b5de680f------2</link>
            <guid isPermaLink="false">https://medium.com/p/a3f5dfeba09</guid>
            <category><![CDATA[diet]]></category>
            <category><![CDATA[longevity]]></category>
            <category><![CDATA[heart-disease]]></category>
            <category><![CDATA[cholesterol]]></category>
            <category><![CDATA[health]]></category>
            <dc:creator><![CDATA[infinome]]></dc:creator>
            <pubDate>Sat, 14 Jul 2018 21:37:02 GMT</pubDate>
            <atom:updated>2018-11-27T20:59:18.683Z</atom:updated>
            <content:encoded><![CDATA[<h4>A followup from : <a href="https://medium.com/@InfinoMe/senescence-links-between-heart-disease-genomics-and-aging-fa78bde773da">Could Aging be an Infectious Disease?</a></h4><p>For decades, we have been fixated on cholesterol as a major factor influencing human health and mortality. It is well established that cholesterol (actually, cholesterol-transporting <a href="https://en.wikipedia.org/wiki/Lipoprotein">lipoproteins</a>) come in “good” and “bad” forms, as the <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747394/">relative levels of these variants is predictive of heart disease</a>. Cholesterol also seems to take center stage in Alzheimer’s since the <a href="https://en.wikipedia.org/wiki/Apolipoprotein_E">APOE</a> gene is a lipoprotein that transports cholesterol in the brain.</p><p>All of this evidence has contributed to the <a href="https://en.wikipedia.org/wiki/Lipid_hypothesis">lipid hypothesis</a>, which has underlined much of public health policy and dietary dogma, and indeed driven the original war between Hi-Carb and Hi-Fat diets. The accumulated evidence is strong, but what if we are inadvertently blaming our bodies natural gene when something far more malicious could be present?</p><p>What if its not the cholesterol, but something else these lipoparticles carry? In <a href="https://medium.com/@InfinoMe/senescence-links-between-heart-disease-genomics-and-aging-fa78bde773da">our last suspenseful episode, we reviewed decades of literature demonstrating links between several common viral infections and the development of both heart disease and Alzheimer’s</a>. Just a few days ago, <a href="https://www.cell.com/neuron/fulltext/S0896-6273(18)30526-9">even more astounding evidence was published demonstrating that amyloid-beta in the brain serves an important role in stopping the spread of herpes virus</a> from neuron to neuron.</p><p>Today, we’ll dive deep into even more startling connections that challenge some of our deepest and long-held dogmas.</p><h3><strong>Getting into the cell</strong></h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/887/0*xWU6zjreUPonSs7D.png" /><figcaption>This way-awesome figure taken from a <a href="http://www.mdpi.com/1999-4915/5/5/1292/htm">great review on the whole pathway</a></figcaption></figure><p>Like a computer virus, a biological virus must get into its host without being detected. What better way than to walk right into the front door with a clever disguise? In computer security, this happens all the time, like an <a href="https://www.social-engineer.org/general-blog/spear-phishing-attacks-breach-podesta-powell-dnc/">innocent looking email that can break an entire democracy</a>.</p><p>In human illness, a profoundly interesting example of this phenomenon is Hepatitis-C virus (HCV). When replicating, it packages itself into a low-density-lipoprotein (LDL) particle, forming a “lipoviralparticle”. These packages then get into cells through the normal endocytic route that is used to deliver cholesterol to all cells of our body, by docking to receptors in a special region of the cell membrane known as a “membrane raft”.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/972/0*93pV5djRfLJxuJkk.jpg" /><figcaption>Hepatitis C literally embeds itself within an LDL (bad cholesterol) particle by binding to APOE. What other viruses might possibly share this same mechanism? <a href="https://www.wjgnet.com/1007-9327/full/v21/i36/10299.htm">Figure from this paper.</a></figcaption></figure><p>Amazingly, part of the Hepatitis-C spread is reliant on the APOE protein, which is the top genetic association with Alzheimer’s. APOE has been shown to exchange from lipoparticles onto viral-infected lipoviral particles, and when this happens, the <a href="http://jvi.asm.org/content/90/21/9632.full">lipoviral particle is better able to avoid the immune system</a>. APOE also appears to play an important role in the development of liver cancer after hepatitis-B infection, and the <a href="https://www.ncbi.nlm.nih.gov/pubmed/26823800">genotype of APOE influences this risk</a>. APOE, in this instance, is serving as a convincing secret agent mustache disguise for both Hep-C and HepB viruses…..</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/645/1*WjirhjkmNkqkE-h5dU9NQw.png" /><figcaption>Yet another kewl diagram from an <a href="https://www.sciencedirect.com/science/article/pii/S0168827817302519">equally kewl publication</a></figcaption></figure><p>Hepatitis C virus thankfully has a relatively rare incidence of <a href="https://www.cdc.gov/hepatitis/hcv/hcvfaq.htm">1 in 100k US persons</a>. Hepatitis B is more common, and is present in <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3290915/">4 out of every 1000 in the US</a>. The human Rhinovirus, however, is the cause of the common cold that we all annoyingly catch from time to time. Totally harmless, right?</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*5kSD5zBZ1v9wPPPo.jpg" /><figcaption>Figure from <a href="http://cmr.asm.org/content/26/1/135.figures-only">this excellent review</a></figcaption></figure><p>Well, Rhinovirus specifically exploits the very low density lipoprotein receptor (vLDLR), effectively entering the target cells through the exact same front door. Once the viral capsule binds, it exploits the cells endocytic machinery to enter the cell and begin replicating. This endosomal trafficking also occurs at membrane rafts.</p><p>While most of us do not take seriously respiratory infections like influenza or the common cold, it should be noted that the <a href="https://onlinelibrary.wiley.com/doi/abs/10.1111/imj.13377">risk of having a heart attack increases 14-fold in the weeks surrounding such infections</a>!</p><p>Lately however, it is herpes simplex virus that has been getting all the attention as a possible cause of Alzheimer’s disease, <a href="https://medium.com/@InfinoMe/senescence-links-between-heart-disease-genomics-and-aging-fa78bde773da">and as we discussed last time, herpes viruses have been shown for decades to be causative for atherosclerosis</a>. It has also been demonstrated that herpes viruses <a href="https://www.ncbi.nlm.nih.gov/pubmed/2842273">bind to several lipoproteins with high affinity</a>, and that they specifically exploit <a href="https://www.ncbi.nlm.nih.gov/pubmed/25421969">oxidized LDL particles to infect endothelial cells of blood vessels</a>. In the brain, <a href="http://jvi.asm.org/content/76/23/12394.full">Herpes-Simplex-Virus-1 has been shown to bind to APOE, and it is APOE that allows the trafficking of lipoproteins into cells</a>.</p><p><strong>Getting out of the cell</strong></p><p>Much like computer viruses, biological viruses must take a delicate approach when they exploit a host. They must avoid detection by the host in order to prevent an Antivirus mechanism from squashing it. They must also avoid killing the host entirely, or they will not proliferate. The most successful viruses, either digital or biological, are those that avoid detection, lurk in their compromised host, and spread as efficiently as possible.</p><p><a href="https://medium.com/@InfinoMe/senescence-links-between-heart-disease-genomics-and-aging-fa78bde773da">As discussed last time</a>, biological <a href="https://www.ncbi.nlm.nih.gov/pubmed/12533696">viruses evade the complement system</a> and optimize the cellular metabolic machinery in order to increase their rate of spread. Furthermore, the best biological viruses have evolved to exit our cells as efficiently as possible without killing them.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/850/0*idvB4KjnzSdhXKfr.png" /><figcaption>This is what influenza virus looks like when it buds from a membrane raft. Figure taken from this <a href="https://www.researchgate.net/publication/256332720_Helical_Membrane_Protein_Conformations_and_their_Environment">totally insanely awesome paper</a></figcaption></figure><p>To accomplish this, many viruses have evolved the ability to “bud” from our cell membranes, primarily at the site of membrane rafts, where a high cholesterol content permits the membrane to be highly flexible. For a detailed overview of these mechanisms shared by a great many viral strains, <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC156468/">these</a> <a href="https://www.ncbi.nlm.nih.gov/pubmed/16880600">two</a> papers are excellent resources.</p><p>Given that several viruses appear to enter the cell at membrane rafts, exit the cell by “budding” from membrane rafts, and exploit binding to both lipoproteins and lipoprotein receptors to easily get around the body and evade the immune system, is it any wonder that the levels of these lipoproteins may influence health and disease? Indeed, <a href="https://www.ncbi.nlm.nih.gov/pubmed/16212526">some studies have shown that cholesterol lowering drugs</a> can <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4244940/">inhibit the spread of some viruses</a>.</p><h3><strong>Alzheimer’s connections</strong></h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*Kb5p7_0zjPQYIk3p.gif" /><figcaption>From <a href="https://atlasofscience.org/lipids-are-major-players-in-alzheimers-disease/">this wickedly cool paper</a></figcaption></figure><p>Alzheimer’s is a disease that is associated with the accumulation of two specific proteins: Beta Amyloid and Phosphorylated Tau. With the recent exciting <a href="https://www.cell.com/neuron/fulltext/S0896-6273(18)30526-9">publication demonstrating that Beta-Amyloid functions as a trap for Herpes viral particles</a>, it is worth discussing where the beta-amyloid comes from. Beta Amyloid protein is secreted primarily at the site of membrane rafts, and as the proteins form aggregates, they maintain a tight binding to these rafts via interactions with the specialized <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677124/">lipids that they are composed of, primarily gangliosides</a>.</p><p>While the accumulation of beta-amyloid between neurons was the first hallmark that <a href="https://en.wikipedia.org/wiki/Alzheimer%27s_disease">Alois Alzheimer</a> originally noticed, the accumulation of a phosphorylated protein called <a href="https://en.wikipedia.org/wiki/Tau_protein">Tau</a> has received much attention due to its formation of “<a href="https://en.wikipedia.org/wiki/Neurofibrillary_tangle">Neurofibrillary tangles</a>” within the neurons. The primary function of Tau, however, is to regulate the stability of <a href="https://en.wikipedia.org/wiki/Microtubule">microtubules within cells, which are used to transport cargo around</a>, among many other functions.</p><p>Microtubules in neurons are critical for the transport of things along the long-lengths of axons, and motor proteins allow the movement of things in both directions. <a href="https://en.wikipedia.org/wiki/Axonal_transport">Anterograde transport moves things towards the synapse at the end of an axon, while retrograde transport moves things back to the cell body.</a> In <a href="https://www.researchgate.net/publication/8086700_Axonal_transport_defects_A_common_theme_in_neurodegenerative_diseases/figures">neurodegenerative disorders, a common theme appears to be defects in this trafficking system</a>, possibly mediated when Tau can no longer do its job.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*hAMO4YWNv3MH5Auv.png" /></figure><p>Retrograde signaling, it turns out, is also the primary mechanism by which Herpes and Rabies viruses infect the nervous system. They specifically travel <strong>backwards </strong>through neural circuits, <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546524/">which many in the literature have proposed as an explanation for how they could enter the brain </a>from the periphery. This transport is actively facilitated by motor proteins that transport virus particles along microtubules.</p><p>And this is the part where I propose something with zero evidence to back it up: Could Tau hyperphosphorylation be an attempt by the cell to halt the progress of a virus? Alternatively, could Tau hyperphosphorylation be a mechanism viruses use to make axonal transport more efficient? Interestingly, it was demonstrated years ago that <a href="https://www.ncbi.nlm.nih.gov/pubmed/22252837">herpes infection causes Tau to become hyperphosphorylated</a>. Despite this find, <a href="https://www.alzforum.org/news/research-news/axonal-transport-not-bothered-tau-elevation-vivo">evidence of Tau’s function in regulating axon transport has been mixed, but experiments do not seem to have not focused on the viral hypothesis</a>.</p><h3>Back to Aging Biology</h3><p>As heart disease and Alzheimer’s are both considered to be diseases of aging, it is useful to revisit the cellular understanding of what aging is. Aging has many <a href="https://www.cell.com/cell/fulltext/S0092-8674(13)00645-4">“hallmark” characteristics</a>, but a dominant model focuses on a state that we call <a href="https://en.wikipedia.org/wiki/Cellular_senescence">cellular replicative senescence</a> in which a cell becomes permanently incapable of dividing. This is widely assumed to be a defense mechanism against cancer, but it has been shown that <a href="https://www.ncbi.nlm.nih.gov/pubmed/20078217">senescent cells secrete a variety of inflammatory molecules that can make an entire tissue sick</a>. It has also been shown in <a href="https://www.npr.org/sections/health-shots/2016/02/03/465354874/boosting-lifespan-by-clearing-out-cellular-clutter">mouse models that simply removing these aged cells can boost lifespan by up to 35%</a>! Unsurprisingly, finding drugs that specifically kill senescent cells has become a booming new industry. (See Unity Biotechnology)</p><p><a href="https://medium.com/@InfinoMe/senescence-links-between-heart-disease-genomics-and-aging-fa78bde773da">As we discussed in our last episode (go read it, seriously!), a common marker for cellular senescence is the p14/p16 gene</a>, which is the top genetic association for heart disease and specifically functions to freeze the cell cycle between the G/S transitions. This cell-cycle checkpoint pathway is exploited by many viruses in order to maximize replication and minimize cell death, including HSV-1.</p><p>The second common marker for cellular senescence that has been embraced by the aging research community is activity of a “<a href="https://en.wikipedia.org/wiki/Senescence-associated_beta-galactosidase">Senescence Associated Beta Galactosidase</a>”. For many years, this was used as a reliable marker for staining senescent cells, <a href="https://www.ncbi.nlm.nih.gov/pubmed/16626397">but it was finally traced to a specific gene GLB1</a>, which is a lysosomal beta-galactosidase enzyme. Rare mutations in this gene cause GM1-gangliosidosis, a disease in which GM1 gangliosides build up within the brain. GM1, you may recall, is considered the primary distinguishing lipid contained within membrane rafts.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/500/0*XDPZJPV-5x8u2U-5.png" /></figure><p>The GM1 lipid headgroup is composed of a galactose sugar, and a special sugar called <a href="https://en.wikipedia.org/wiki/N-Acetylmuramic_acid">N-</a>Acetylneuraminic<a href="https://en.wikipedia.org/wiki/N-Acetylmuramic_acid"> acid</a>, which is also called “Sialic Acid”. Several viruses, including influenza, specifically bind to GM1 molecules at these headgroups. Ironically, influenza viruses exploit an enzyme that degrades neuraminic acid, neuraminidase, to facilitate this binding and allow cell entry. The version of this protein is the “N” in influenza strain designations such as “H5<strong>N</strong>1”.</p><p>Given that in our last writeup, we discussed how p14/p16 expression and cell-cycle locking can be exploited by viral infections, it may be that overexpression of the senescence associated beta-galactosidase (GLB1) is a similarly important antiviral defense. By degrading the population of GM1 gangliosides in a cell, this may potentially limit viral entry in much the same way that beta-amyloid aggregated can prevent export by binding to the external face of the cell.</p><p>This second connection between cellular senescence and viral replication warrants followup, and preferably communication between the aging field and virology field.</p><p><strong>============ In closing</strong></p><p>Have we needlessly blamed our good friend LDL, who has always been there to deliver cholesterol to peripheral tissues in need? Is it possible that we have become far too fixated on simple answers for explaining all of our common health problems, and consequently obsessed over simple solutions (like low-carb or low-fat dieting), when in fact we should focus on more nuanced explanations for what kills us?</p><p>Maybe we should stop shooting the messenger, and while we’re at it, stop blaming sick people for their dietary choices?</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*OSWt-sLc_ZInULsNk5SrZA.png" /></figure><p>================</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*zyTIpLGfTfiUXR6a" /></figure><blockquote><strong>Rorty</strong>: I’ve got nothing but bad memories about these lipoproteins Mick. Everytime they show up, it seems that atherosclerosis develops and a heart attack eventually ruins everything.</blockquote><blockquote><strong>Mick</strong>: That’s because of the parasites Rorty! These viruses are hiding inside our own lipoproteins to sneak around our bodies. They’ve even convinced us to attack our own friends, through autoimmune reactions!</blockquote><blockquote>Lets go, we’ve got lots of our own healthy lipoparticles to exterminate.</blockquote><p>=================</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=a3f5dfeba09" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Could Aging be an Infectious Disease?]]></title>
            <link>https://medium.com/@InfinoMe/senescence-links-between-heart-disease-genomics-and-aging-fa78bde773da?source=rss-35f9b5de680f------2</link>
            <guid isPermaLink="false">https://medium.com/p/fa78bde773da</guid>
            <category><![CDATA[longevity]]></category>
            <category><![CDATA[health]]></category>
            <category><![CDATA[aging]]></category>
            <category><![CDATA[alzheimers]]></category>
            <category><![CDATA[heart-disease]]></category>
            <dc:creator><![CDATA[infinome]]></dc:creator>
            <pubDate>Sat, 23 Jun 2018 20:26:04 GMT</pubDate>
            <atom:updated>2019-02-28T19:59:46.351Z</atom:updated>
            <content:encoded><![CDATA[<p>Making the case that aging could be primarily driven by infections, told from the perspective of a future “Mick and Rorty” episode … for kicks</p><p><strong>NOTE</strong>: This writeup has been moved to our new on-site blog. Find it here : <a href="https://blog.infino.me/could-aging-be-an-infectious-disease/">https://blog.infino.me/could-aging-be-an-infectious-disease/</a></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*iWhxGLgzMKD3OzEo.jpg" /></figure><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=fa78bde773da" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Staying Young With Old Data]]></title>
            <link>https://medium.com/@InfinoMe/staying-young-with-old-data-6e4e7ccae964?source=rss-35f9b5de680f------2</link>
            <guid isPermaLink="false">https://medium.com/p/6e4e7ccae964</guid>
            <category><![CDATA[aging]]></category>
            <category><![CDATA[health]]></category>
            <category><![CDATA[heart-disease]]></category>
            <category><![CDATA[longevity]]></category>
            <category><![CDATA[alzheimers]]></category>
            <dc:creator><![CDATA[infinome]]></dc:creator>
            <pubDate>Sat, 23 Jun 2018 19:46:43 GMT</pubDate>
            <atom:updated>2018-09-15T00:27:56.072Z</atom:updated>
            <content:encoded><![CDATA[<p>Way back in 2009, a fascinating meta-analysis was performed across 27 prior studies that previously looked for genes significantly overexpressed and underexpressed with advanced age. This study combined datasets from Human, Mouse, and Rat studies, involving a wide variety of tissues.</p><p>João Pedro de Magalhães, João Curado, and George M. Church : <a href="https://academic.oup.com/bioinformatics/article/25/7/875/210443"><strong>Meta-analysis of age-related gene expression profiles identifies common signatures of aging</strong></a></p><p>Since this meta analysis was performed, a number of genes have been further investigated. This post documents the results of my deep dive into the literature, further elucidating the mechanisms that the original authors began to piece together. Since this publication, much has been learned about many of these genes, and indeed many of them seem to fit a few core themes that may underlie aging of all tissues, as well as mechanistic drivers of alzheimer’s and cardiovascular disease.</p><p>Figure 1 from the paper shows a lovely visualization of the Over (left) and Under (right) expressed genes. What we find in this dataset, after extensive literature review, are a few core themes : Complement cascade of the innate immune system, Collagen degradation and synthesis, mitochondrial function, and defense against Reactive Oxygen Species (ROS).</p><p><a href="https://academic.oup.com/view-large/figure/83344337/btp073f1.jpeg">Meta-analysis of age-related gene expression profiles identifies common signatures of aging | Oxford Academic</a></p><blockquote>The rest that follows is copied directly from a google doc, and will be cleaned up later. Feel free to comment there, if you would like : <a href="https://docs.google.com/document/d/1SmNBW3RaKvGK11cgikDB4IWQy8Q7WIUbIhsw1Xq7EAs/edit?usp=sharing">https://docs.google.com/document/d/1SmNBW3RaKvGK11cgikDB4IWQy8Q7WIUbIhsw1Xq7EAs/edit?usp=sharing</a> ]</blockquote><blockquote>Like many lame websites from the 90s, everything that follows is under construction :</blockquote><figure><img alt="" src="https://cdn-images-1.medium.com/max/300/0*o9Os90Ba9rVGUcdc.gif" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/921/0*ovsPX0VMdKY3b0Zv" /><figcaption>Some preliminary network analysis of the genes over (orange) and under (blue) expressed in aging.</figcaption></figure><p>Note to self, follow up on this : <a href="https://www.nature.com/articles/s41591-018-0159-7">https://www.nature.com/articles/s41591-018-0159-7</a></p><h3>Overexpressed with age</h3><h3>APOD : Apolioprotein D</h3><p>This is the top overexpressed gene in the paper in many aging tissues.</p><p>- Nice review of its role in aging : <a href="https://www.tandfonline.com/doi/pdf/10.4161/cc.9.2.10433">https://www.tandfonline.com/doi/pdf/10.4161/cc.9.2.10433</a></p><p>- has estrogen/progesterone response elements — because of this, higher amounts are found in women. Women also live longer</p><p>- Note : Quercetin is senolytic, and it activates estrogen receptors : <a href="https://www.scientificamerican.com/article/to-stay-young-kill-zombie-cells/">https://www.scientificamerican.com/article/to-stay-young-kill-zombie-cells/</a></p><p>- it also binds and transports progesterone in the body : <a href="https://www.rcsb.org/structure/2hzq">https://www.rcsb.org/structure/2hzq</a></p><p>- “These reports clearly identify ApoD as a “suspect at many different crime scenes,” including the aging brain”</p><p>- Blood concentrations of protein rise with age and Parkinsons : <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892211/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892211/</a></p><p>-APOD has a conserved methionine whos job is to reduce lipid peroxides. The methionine becomes oxidized, and APOD then dimerizes. Alzheimers brains are filled with dimerized and inactive APOD, along with lipid peroxides : <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988949/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988949/</a></p><p>- APOD found in atherosclerotic plaques : <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784685/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784685/</a></p><p>- mutations in APOD associated with CVD : <a href="http://www.jbc.org/content/282/42/31068.long">http://www.jbc.org/content/282/42/31068.long</a></p><p>- Extends lifespan / stress resistance in Drosophila : <a href="http://www.pnas.org/content/105/19/7088.short">http://www.pnas.org/content/105/19/7088.short</a></p><p>- Binds/inhibits <strong>osteopontin</strong> (<strong>SPP1</strong>, also in this list, below!) :<a href="https://www.ncbi.nlm.nih.gov/pubmed/17089001"> https://www.ncbi.nlm.nih.gov/pubmed/17089001</a></p><p>- SPP1 is the top overexpressed gene in atherosclerosis in this paper : <a href="https://www.nature.com/articles/srep41483">https://www.nature.com/articles/srep41483</a></p><p>- APOD is involved in the mechanisms regulating protection from oxidative stress : <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2574913/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2574913/</a></p><p>- APOD preferentially binds to Arachidonic acid (an omega-6), which is oxidized in various tissues. Isoprostane is an oxidized product of AA, and can be measured in urine as a way of assessing oxidative stress! : <a href="https://www.ncbi.nlm.nih.gov/pubmed/22760572">https://www.ncbi.nlm.nih.gov/pubmed/22760572</a></p><p>- This paper provides molecular simulations of APOD binding to a peroxidized eicosanoid 5s-HETE : <a href="https://www.ncbi.nlm.nih.gov/pubmed/22479522">https://www.ncbi.nlm.nih.gov/pubmed/22479522</a></p><p>-This eicosanoid is synthesized from Arachidonic Acid by the enzyme ALOX5, which is associated with diseases including arthritis, atherosclerosis, IBS, and autoimmune diseases : <a href="https://en.wikipedia.org/wiki/Arachidonate_5-lipoxygenase">https://en.wikipedia.org/wiki/Arachidonate_5-lipoxygenase</a></p><p>-5s-Hete is fascinating : “The selective synthesis of 5(<em>S</em>)-HETE (i.e. synthesis of 5(<em>S</em>)-HETE without concurrent synthesis of 5(<em>R</em>)-HETE) by cells is dependent on, and generally proportionate to, the presence and levels of its forming enzyme, ALOX5. Human ALOX5 is highly expressed in cells that regulate <a href="https://en.wikipedia.org/wiki/Innate_immunity">innate immunity</a> responses, particularly those involved in <a href="https://en.wikipedia.org/wiki/Inflammation">inflammation</a> and <a href="https://en.wikipedia.org/wiki/Allergy">allergy</a>. Examples of such cells include <a href="https://en.wikipedia.org/wiki/Neutrophils">neutrophils</a>, <a href="https://en.wikipedia.org/wiki/Eosinophils">eosinophils</a>, <a href="https://en.wikipedia.org/wiki/B_lymphocytes">B lymphocytes</a>, <a href="https://en.wikipedia.org/wiki/Monocytes">monocytes</a>, <a href="https://en.wikipedia.org/wiki/Macrophages">macrophages</a>, <a href="https://en.wikipedia.org/wiki/Mast_cells">mast cells</a>, <a href="https://en.wikipedia.org/wiki/Dendritic_cells">dendritic cells</a>, and the <strong>monocyte-derived </strong><a href="https://en.wikipedia.org/wiki/Foam_cells"><strong>foam cells</strong></a><strong> of </strong><a href="https://en.wikipedia.org/wiki/Atherosclerosis"><strong>atherosclerosis</strong></a><strong> tissues</strong>”</p><p>-APOD Binds to the leptin receptor in the brain and may mediate connections between aging and obesity : <a href="https://www.researchgate.net/publication/11993568_Apolipoprotein_D_interacts_with_the_long_form_leptin_receptor_A_hypothalamic_function_in_the_control_of_energy_homeostasis">https://www.researchgate.net/publication/11993568_Apolipoprotein_D_interacts_with_the_long_form_leptin_receptor_A_hypothalamic_function_in_the_control_of_energy_homeostasis</a></p><p>-Interestingly, APOD expression in the brain positively correlates with high fat diet. Perhaps its a part of leptin resistance and hypothalamic aging!</p><p>-Since fat mass increases with age in practically everyone, this is a neat finding</p><h4>FCGR2B : Low affinity immunoglobulin gamma Fc receptor II-b</h4><p>-This is an inhibitory FC region for an antibody. In the body, it attenuates autoimmune reactions.</p><p>-In this study, they demonstrated that by knocking it down, autoimmune reactions lead to atherosclerosis! They also demonstrated that macrophages lacking this gene were defective in phagocytosis. <a href="https://www.fasebj.org/doi/full/10.1096/fj.201500131">https://www.fasebj.org/doi/full/10.1096/fj.201500131</a></p><p>-They classify a set of proteins in plaques that antibodies attacked. These include Fibulin 5 (Fibulin 3 is in this list), and Annexin A1 (A3 and A5 in this list)</p><h4>C3 : Complement component 3</h4><p>- Part of innate immunity — lower in this report we document that <strong>3 C1Q</strong> genes are represented, along with <strong>C4</strong>, also overexpressed in aging</p><p>- Activated C3b binds to complement-receptor-1 (CR1) — a top alzheimers/CVD gwas hit : <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3896259/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3896259/</a></p><p>- C3 variants associated with macular degeneration : <a href="https://www.infino.me/gene/c3/">https://www.infino.me/gene/c3/</a></p><p>- C3 is secreted in proximal tubules in the kidney when transferrin levels are high (note that transferrin receptor is the most underexpressed gene, below) : <a href="https://www.ncbi.nlm.nih.gov/pubmed/11136173">https://www.ncbi.nlm.nih.gov/pubmed/11136173</a></p><h4>CLU : Clusterin</h4><p>- 4th most important GWAS locus for alzheimers : <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3896259/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3896259/</a></p><p>- Binds to Ku70, a DNA repair gene that causes premature aging in mice when knocked out. Perhaps it suppresses its activity? : <a href="https://en.wikipedia.org/wiki/Ku70">https://en.wikipedia.org/wiki/Ku70</a> and <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964162/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964162/</a></p><h4>CTSS : Cathepsin S — lysosomal cysteine protease</h4><p>- “a lysosomal cysteine proteinase that may participate in the degradation of antigenic proteins to peptides for presentation on MHC class II molecules” — <a href="https://www.ncbi.nlm.nih.gov/gene/1520">https://www.ncbi.nlm.nih.gov/gene/1520</a></p><p>- Collagen connections (see underexpressed genes list) : “Secreted cathepsin S cleaves some <a href="https://en.wikipedia.org/wiki/Extracellular_matrix">extracellular matrix</a> (ECM) proteins. Cathepsin S may be considered the most potent elastase known. The list of proposed cathepsin S substrates includes <a href="https://en.wikipedia.org/wiki/Laminin">laminin</a>, fibronectin elastin, <a href="https://en.wikipedia.org/wiki/Osteocalcin">osteocalcin</a> and some <a href="https://en.wikipedia.org/wiki/Collagen">collagens</a>. It also cleaves <a href="https://en.wikipedia.org/wiki/Chondroitin_sulfate">chondroitin sulfate</a>, <a href="https://en.wikipedia.org/wiki/Heparan_sulfate">heparan sulfate</a> and <a href="https://en.wikipedia.org/wiki/Proteoglycan">proteoglycans</a> of the <a href="https://en.wikipedia.org/wiki/Basal_membrane">basal membrane</a>. Cathepsin S plays an active role in blood vessels permeability and <a href="https://en.wikipedia.org/wiki/Angiogenesis">angiogenesis</a> due to its elastolytic and collagenolytic activities.” — <a href="https://en.wikipedia.org/wiki/Cathepsin_S">https://en.wikipedia.org/wiki/Cathepsin_S</a></p><h4>LYZ : lysozyme</h4><p>- degrades bacterial cell walls by breakdown of <a href="https://en.wikipedia.org/wiki/N-acetylmuramic_acid">N-acetylmuramic acid</a> and <a href="https://en.wikipedia.org/wiki/N-acetyl-D-glucosamine">N-acetyl-D-glucosamine</a> (NAG)</p><p>- Note: NAG is also known as GlcNac, and o-GlcNac is a protein modification is associated with aging pathologies. Could LYZ modulate it too? : <a href="https://www.sciencedirect.com/science/article/pii/S0098299716300127">https://www.sciencedirect.com/science/article/pii/S0098299716300127</a></p><p>- O-GlcNAc and aging: C. elegans as a genetic model to test O-GlcNAc roles in type II diabetic insulin resistance:</p><p>“An insulin receptor-like mutant allele (daf-2) with reduced signaling induces dauer formation, and this was enhanced by an OGA null mutant which elevated O-GlcNAc [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3006014/#R3">3</a>], and inhibited by an OGT null mutant which reduced O-GlcNAc levels”</p><p><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3006014/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3006014/</a></p><p>- According to wikipedia, when NAG polymerizes with glucoronic acid, you get hyaluronan, the molecule found to be upregulated in naked mole rats : <a href="https://en.wikipedia.org/wiki/N-Acetylglucosamine">https://en.wikipedia.org/wiki/N-Acetylglucosamine</a></p><p>- Glucosamine residues form the core of the LPS o-antigen, which causes LPS toxicity</p><h4>IGJ : J-chain of immunoglobulin</h4><p>- Connects Fc regions of antibodies in IGA and IGM particles</p><p>- Important in Complement inhibition : ”The J-chain also plays a role in the activation of complement. J-chain negative IgM hexamers are 15–20 times more effective at activating <a href="https://en.wikipedia.org/wiki/Complement_system">complement</a> than J-chain positive IgM pentamers.<a href="https://en.wikipedia.org/wiki/J_chain#cite_note-Johansen2000-11">[11]</a> A consequence of this lack of complement activation is it allows J-chain positive pIgM to bind antigens without causing excessive damage to epithelial membranes through complement activation.” — <a href="https://en.wikipedia.org/wiki/J_chain">https://en.wikipedia.org/wiki/J_chain</a></p><p>- Perhaps the increased expression of this gene is a way of defending itself from elevated complement. There is evidence for this. B-cells have been shown to secrete IGM molecules that bind to LDL particles when they become oxidized : <a href="https://www.ncbi.nlm.nih.gov/pubmed/26082558">https://www.ncbi.nlm.nih.gov/pubmed/26082558</a></p><p>- Do IgM antibodies protect against atherosclerosis in Lupus? : <a href="https://www.nature.com/articles/nrrheum.2016.108.pdf?origin=ppub">https://www.nature.com/articles/nrrheum.2016.108.pdf?origin=ppub</a></p><p>- IGM is Required for Protection Against Atherosclerosis in LDL Receptor-Deficient Mice : <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2761224/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2761224/</a></p><p>- Could there be a treatment here? Could IgM be injected that would recognize oxidized LDL, preventing it from binding free IgG and causing a complement cascade?</p><h4>Complement Component 1q : multiple genes (C1QA, C1QB, C1QC)</h4><p>Initiates the classical complement cascade <a href="https://en.wikipedia.org/wiki/Complement_component_1q">https://en.wikipedia.org/wiki/Complement_component_1q</a> (Ive moved B and C up in ordering)</p><p>“The antibodies <a href="https://en.wikipedia.org/wiki/IgM">IgM</a> and all <a href="https://en.wikipedia.org/wiki/IgG">IgG</a> subclasses except <a href="https://en.wikipedia.org/wiki/Immunoglobulin_G#Subclasses">IgG4</a> are able to initiate the complement system.”</p><p>“C1q is composed of 18 polypeptide chains: six A-chains, six B-chains, and six C-chains. Each chain contains a <strong>collagen-like region</strong> located near the N terminus and a C-terminal globular region. The A-, B-, and C-chains are arranged in the order A-C-B on chromosome 1”</p><p>“The 80-amino acid helical component of each triple peptide contain many Gly-X-Y sequences, where X and Y are <a href="https://en.wikipedia.org/wiki/Proline">proline</a>, <a href="https://en.wikipedia.org/wiki/Isoleucine">isoleucine</a>, or <a href="https://en.wikipedia.org/wiki/Hydroxylysine">hydroxylysine</a>; they, therefore, <strong>strongly resemble </strong><a href="https://en.wikipedia.org/wiki/Collagen"><strong>collagen</strong></a><strong> </strong><a href="https://en.wikipedia.org/wiki/Fibrils"><strong>fibrils</strong></a><strong>.”</strong></p><p>- C1Q causes multiple aging related phenotypes: <a href="https://www.cell.com/cell/fulltext/S0092-8674(12)00531-4">https://www.cell.com/cell/fulltext/S0092-8674(12)00531-4</a></p><p><strong>C1QA</strong> : Complement component 1Q, subunit c</p><p><strong>C1QB</strong> : Complement component 1Q, subunit c</p><p><strong>C1QC</strong> : Complement component 1Q, subunit c</p><h4>S100A6</h4><p>-Member of s100 family of proteins that contain 2 Calcium binding EF-hand motifs. See also <strong>S100A4</strong> (below)</p><p>-Binds to S100B protein, which binds calcium and zinc. S100B binds to Tau and controls its phosphorylation (alzheimers and other dementias) <a href="https://www.ncbi.nlm.nih.gov/pubmed/2833519">https://www.ncbi.nlm.nih.gov/pubmed/2833519</a></p><h4>MT1F : Metalothionen</h4><p>- Has lots of cycstein residues and soaks up heavy metals : Copper, Cadmium, zinc — upregulated by metals and glucocorticoids</p><p>-This gene is so metal</p><p>- Note, Copper and Zinc are required for SOD1 to work properly to clear free radicals</p><p>- Some evidence that metalothionen may enhance SOD activity by gathering needed cofactors? :</p><p>“The combination of metallothionein and superoxide dismutase protects pancreatic β cells from oxidative damage.”</p><p><a href="https://www.ncbi.nlm.nih.gov/pubmed/22069263">https://www.ncbi.nlm.nih.gov/pubmed/22069263</a></p><p>- Antioxidative roles of metallothionein and manganese superoxide dismutase induced by tumor necrosis factor-alpha and interleukin-6. :</p><p>“These data strongly suggest that MT and Mn-SOD in the liver cooperatively play antioxidative roles.”</p><p><a href="https://www.ncbi.nlm.nih.gov/pubmed/7532385">https://www.ncbi.nlm.nih.gov/pubmed/7532385</a></p><p>Excess copper might be bad!</p><p>- Copper‐Dependent Oxidative Stress and Neurodegeneration : <a href="https://iubmb.onlinelibrary.wiley.com/doi/abs/10.1080/713803724">https://iubmb.onlinelibrary.wiley.com/doi/abs/10.1080/713803724</a> “This review will cover some aspects of the involvement of copper‐mediated oxidative stress in degenerative processes in the central nervous system, with special focus on the familial form of amyotrophic lateral sclerosis (FALS)”</p><p>-”Mitochondrial Dysfunction in Neurodegenerative Diseases Associated with Copper Imbalance“ <a href="https://link.springer.com/article/10.1023/B:NERE.0000014820.99232.8a">https://link.springer.com/article/10.1023/B:NERE.0000014820.99232.8a</a></p><p>“Copper is an essential transition metal ion for the function of key metabolic enzymes, but its uncontrolled redox reactivity is source of reactive oxygen species. Therefore a network of transporters strictly controls the trafficking of copper in living systems. Deficit, excess, or aberrant coordination of copper are conditions that may be detrimental, especially for neuronal cells, which are particularly sensitive to oxidative stress. Indeed, the genetic disturbances of copper homeostasis, Menkes’ and Wilson’s diseases, are associated with neurodegeneration. Furthermore, copper interacts with the proteins that are the hallmarks of neurodegenerative disorders, such as Alzheimer’s disease, Parkinson’s disease, prion diseases, and familial amyotrophic lateral sclerosis. In all cases, copper-mediated oxidative stress is linked to mitochondrial dysfunction, which is a common feature of neurodegeneration. In particular we recently demonstrated that in copper deficiency, mitochondrial function is impaired due to decreased activity of cytochrome c oxidase, leading to production of reactive oxygen species, which in turn triggers mitochondria-mediated apoptotic neurodegeneration.”</p><h4>LGALS3 : Galectin-3</h4><p>-Galactose-specific lectin that binds IgE</p><p>-”Galactose-specific lectin which binds IgE. May mediate with the alpha-3, beta-1 integrin the stimulation by CSPG4 of endothelial cells migration. Together with DMBT1, required for terminal differentiation of columnar epithelial cells during early embryogenesis (By similarity). In the nucleus: acts as a pre-mRNA splicing factor. Involved in acute inflammatory responses including neutrophil activation and adhesion, chemoattraction of monocytes macrophages, opsonization of apoptotic neutrophils, and activation of mast cells.” <a href="http://www.uniprot.org/uniprot/P17931">http://www.uniprot.org/uniprot/P17931</a></p><p>-Galectin-3 gene (<em>LGALS3</em>) expression in experimental atherosclerosis and cultured smooth muscle cells : “The <a href="https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/galectin-3">galectin-3</a> gene (<a href="https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/galectin-3"><em>LGALS3</em></a>) encodes a β-galactose binding <a href="https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/lectin">lectin</a>.” — <a href="https://www.sciencedirect.com/science/article/pii/S0014579398006838">https://www.sciencedirect.com/science/article/pii/S0014579398006838</a></p><p>-With other markers, is a strong biomarker of cardiac stress <a href="https://en.wikipedia.org/wiki/ST2_cardiac_biomarker">https://en.wikipedia.org/wiki/ST2_cardiac_biomarker</a></p><p>-Is upregulated in pulmonary fibrosis, a disease characterized by abnormal <strong>collagen</strong> accumulation : <a href="https://en.wikipedia.org/wiki/Galectin-3#Biomarkers">https://en.wikipedia.org/wiki/Galectin-3#Biomarkers</a></p><p>-Inhibition of Galectin-3 significantly reduced portal hypertension and fibrosis in mice (also wikipedia ^)</p><p>-Along with <strong>MPEG1</strong>, this gene is overexpressed in muscular dystrophy mice: <a href="https://academic.oup.com/hmg/article-pdf/11/3/263/9464647/110263.pdf">https://academic.oup.com/hmg/article-pdf/11/3/263/9464647/110263.pdf</a></p><p>-Note, the fact that LGALS3 binds to beta-galactose is interesting. Senescence is associated with increased beta-galactosidase activity : <a href="https://en.wikipedia.org/wiki/Senescence-associated_beta-galactosidase">https://en.wikipedia.org/wiki/Senescence-associated_beta-galactosidase</a></p><p>-In fact, this paper says this gene is secreted in the SASP state! : <a href="https://www.sciencedirect.com/science/article/pii/S0022202X15390394">https://www.sciencedirect.com/science/article/pii/S0022202X15390394</a></p><p>-Galectin3 is alternatively named the “AGE receptor 3” : <a href="https://www.ncbi.nlm.nih.gov/pubmed/10997688">https://www.ncbi.nlm.nih.gov/pubmed/10997688</a></p><p>-Note: evidently galactosyl-hydroxylysine is a common modification in collagen! : <a href="https://www.sciencedirect.com/science/article/pii/B9780123738844000203">https://www.sciencedirect.com/science/article/pii/B9780123738844000203</a></p><p>-From 1971: collagen has 12% glucose+galactose content : <a href="http://www.sciencedirect.com/science/article/pii/0006291X71900738/pdf">www.sciencedirect.com/science/article/pii/0006291X71900738/pdf</a></p><p>-Galectin 3 mediates adhesion of cells to collagens 1 and 4, by mediating interactions with the collagen receptor integrin α2β1, which is primarily expressed in platelets and epithelial cells : <a href="http://www.jbc.org/content/283/47/32264.full">http://www.jbc.org/content/283/47/32264.full</a></p><h4>MGST1 : Microsomal glutathione s-transferase 1</h4><p>-Cleans up lipid peroxides, localizes to the mitochondrial membrane and ER : <a href="https://en.wikipedia.org/wiki/Microsomal_glutathione_S-transferase_1">https://en.wikipedia.org/wiki/Microsomal_glutathione_S-transferase_1</a></p><h4>ANXA3 : Annexin A3</h4><p><strong>-</strong>Member of family of calcium-dependent phospholipid-binding protein regulates cell growth and signal transduction pathways. Inhibits phospholipase A2 and cleaves inositol 1,2-cyclic phosphate to 1-phosphate. May also play a role in anti-coagulation : <a href="https://en.wikipedia.org/wiki/Annexin_A3">https://en.wikipedia.org/wiki/Annexin_A3</a></p><p>-Inihibition of phospholipase A2 may cause less arachidonic acid to be formed. That would block phospholipids in the membrane from being converted to arachidonic acid. Note that aspirin effect is one step later killing COX-1 and 2 enzyme that convert arachidonic acid to pro-inflammatory prostaglandin.</p><h4>ANXA5 : Annexin A5</h4><p>-Used in assays to detect apoptotic cells by binding phosphatidylserine (marker of apoptosis, important in signaling). May play role in inhibition of blood coagulation by competing for phosphatidylserine binding sites with prothrombin. Also inhibits activity of phospholipase A1. <a href="https://en.wikipedia.org/wiki/Annexin_A5">https://en.wikipedia.org/wiki/Annexin_A5</a></p><h4>S100A4 : calcium binding protein</h4><p>-” considered a specific fibroblast maker, and thus is frequently used to monitor or predict the mechanism of tissue fibrosis” — causes pulmonary fibrosis and directly signals fibroblasts to secrete fibronectin and collagen <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702147/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702147/</a></p><p>-associates with the RAGE (Receptor of advanced glycation endproducts) <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762817/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762817/</a></p><p>- which senses AGE’s and activates NFKb pathway, which causes TNF-alpha to be secreted and lead to an inflammatory cascade</p><p>-The RAGE receptor becomes activated by N-Acetyl-Glucosamine and other glycosaminoglycans, including heparan sulfate!</p><p>- WTF biology …. The basement membrane of blood vessels is made of GAGs and NAGs! WHY YOU ATTACKING YOU!?!?</p><p><a href="https://www.ncbi.nlm.nih.gov/pubmed/23360476">https://www.ncbi.nlm.nih.gov/pubmed/23360476</a></p><p>-A drug exists which blocks this binding between S100A4 and RAGE : <a href="http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0063012">http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0063012</a></p><p>-This drug is used for autoimmune conditions in farm animals … and is available in bulk on alibaba …..</p><h4>GPNMB : Osteoactivin</h4><p>-Highly expressed during chondrogenesis (cartilage formation) and osteogenesis : <a href="https://en.wikipedia.org/wiki/GPNMB">https://en.wikipedia.org/wiki/GPNMB</a></p><p>-Note: cartilage is composed of collagen and proteoglycans in differing amounts : <a href="https://en.wikipedia.org/wiki/Cartilage">https://en.wikipedia.org/wiki/Cartilage</a></p><p>-Osteoactivin has a heparan binding domain, and is HEAVILY glycosylated with <strong>NAG</strong> modifications: <a href="https://www.bioagilytix.com/biomarkers/osteoactivin/">https://www.bioagilytix.com/biomarkers/osteoactivin/</a></p><p>-Elevated and cytoprotective in ALS motor neurons : <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711880/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711880/</a></p><ul><li>Along with <strong>spp1</strong> (osteopontin, below), primarily regulated by MITF transcription factor</li><li>More here on SPP1/TRAP/MITF connections : <a href="http://www.jbc.org/content/282/3/1891.full.html">http://www.jbc.org/content/282/3/1891.full.html</a></li></ul><h4>GSTA1 : Glutathione S-transferase 1</h4><p>-Ros scavenger in cytosol</p><h4>VWF : Von Willebrand factor</h4><p>-Important in clotting and wound healing — defects in this gene lead to chronic nosebleeds, GI bleeding, etc</p><p>-Directly binds to <strong>COL1A1</strong>, which is in the underexpressed gene list : <a href="https://www.ncbi.nlm.nih.gov/pubmed/3490481">https://www.ncbi.nlm.nih.gov/pubmed/3490481</a></p><p>-VWF binds to the LPR1 receptor, which is the receptor for APO-E, the top causative genetic factor for alzheimers, and also associated with CVD</p><p>- Macrophages use LPR1 to clear VWF, as well as lipoproteins. Knocking it out of macrophages leads to elevated VWF and lipoproteins</p><p><a href="https://www.ncbi.nlm.nih.gov/pubmed/22234691">https://www.ncbi.nlm.nih.gov/pubmed/22234691</a> and</p><p>-From wikipedia :</p><p><em>“In thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS), ADAMTS13 either is deficient or has been inhibited by antibodies directed at the enzyme. This leads to decreased breakdown of the ultra-large multimers of vWF and microangiopathic hemolytic anemia with deposition of fibrin and platelets in small vessels, and capillary necrosis. In TTP, the organ most obviously affected is the brain; in HUS, the kidney.[12] Higher levels of vWF are more common among people that have had ischemic stroke (from blood-clotting) for the first time.[13] Occurrence is not affected by ADAMTS13, and the only significant genetic factor is the person’s blood group. High plasma vWF levels were found to be an independent predictor of major bleeding in anticoagulated atrial fibrillation patients.[14]”</em></p><p>So, if the enzyme that chews VWF is broken, VWF is elevated and fibrin and platelets are deposited in small vessels? Sounds like more of a fibrosis story ….</p><h4>DERL1 : Derlin-1</h4><p>“Derlin-1 is part of a complex (that includes VIMP, SEL1, HRD1, and HERP) that mediates endoplasmic-reticulum-associated degradation (ERAD) that detects misfolded proteins in the endoplasmic reticulum and targets them for destruction.”</p><h4>NDRG1</h4><p>-</p><h4>ANIA4 : Renamed Dclk1 : doublecortin-like kinase 1</h4><p>-A marker for Tuft cells, which are cilliated cells lining the GI and respiratory tracts with special chemosensory receptors. They only show up when parasitic infections or allergans are present, and specific cytokines are released that cause them to develop. This leads to a type-2 immunity. It’s mostly overexpressed in the CNS in this dataset, but slightly overexpressed in lung, which is interesting because they are responsible for helper-T cell mediated asthma reactions in mice when given <strong>IL33</strong>, also present in this dataset and associated with pulmonary fibrosis <a href="https://en.wikipedia.org/wiki/Tuft_cell">https://en.wikipedia.org/wiki/Tuft_cell</a></p><h4>FCGR2A</h4><ul><li>Antibody component Associated with autoimmune diseases, Lupus</li><li>Along with C1QBP, this gene is associated with influenza severity …. Suggesting that this may be upregulated to fight viral infections <a href="http://www.mir-journal.org/files/02_02_kiselev_en2.pdf">http://www.mir-journal.org/files/02_02_kiselev_en2.pdf</a></li></ul><p>- This gene functions as a high-affinity receptor for C-reactive protein (CRP) in leukocytes. <a href="https://www.omim.org/entry/146790">https://www.omim.org/entry/146790</a></p><p>- This gene binds to serum amyloid P component, and other proteins of the pentraxin family. SAP is 14% of amyloid deposits in many tissues. SAP is part of the pentraxin gene family, and has 51% homology with C-reactive protein : <a href="https://en.wikipedia.org/wiki/Serum_amyloid_P_component">https://en.wikipedia.org/wiki/Serum_amyloid_P_component</a></p><p>-Interestingly, the SAP localizes to atherosclerotic lesions, and binds directly to HDL and vLDL lipoproteins. “These results suggest that the function of SAP is related to its capability to interact with lipoproteins and this may have important implications in atherosclerosis and in amyloidosis.” <a href="https://www.sciencedirect.com/science/article/pii/S0006291X98982481?via%3Dihub">https://www.sciencedirect.com/science/article/pii/S0006291X98982481?via%3Dihub</a></p><h4>GBP2</h4><p>-</p><h4>GNS : N-acetylglucosamine-6-sulfatase (NAG!)</h4><p>-”It is involved in the <a href="https://en.wikipedia.org/wiki/Catabolism">catabolism</a> of <a href="https://en.wikipedia.org/wiki/Heparin">heparin</a>, <a href="https://en.wikipedia.org/wiki/Heparan_sulphate">heparan sulphate</a>, and <a href="https://en.wikipedia.org/wiki/Keratan_sulphate">keratan sulphate</a>.<a href="https://en.wikipedia.org/wiki/N-acetylglucosamine-6-sulfatase#cite_note-entrez-5">[5]</a>”</p><p>-Deficiency of this enzyme results in a lysosomal storage disorder (Sanfilippo D syndrome)</p><p>-Note, Lysozyme above also degrades NAG, but in bacterial cell walls</p><p>-In recent years, heparin has become very relevant in the pathogenesis of alzheimer’s and possibly other neurodegenerative diseases</p><p>-Heparan binds and activates BACE1, an enzyme that processes beta-amyloid : <a href="https://www.ncbi.nlm.nih.gov/pubmed/16716081">https://www.ncbi.nlm.nih.gov/pubmed/16716081</a></p><p>-Heparan Sulfate Proteoglycans are involved in the trans-synaptic transport of tau aggregates in the spread of alzheimers : <a href="http://www.pnas.org/content/110/33/E3138">http://www.pnas.org/content/110/33/E3138</a></p><p>-”Neuronal heparan sulfates promote amyloid pathology by modulating brain amyloid-β clearance and aggregation in Alzheimer’s disease.”</p><p><a href="https://www.ncbi.nlm.nih.gov/pubmed/27030596">https://www.ncbi.nlm.nih.gov/pubmed/27030596</a></p><p>-Warning, the biology of Heparin Sulfates is a DEEP rabbit hole … : <a href="https://en.wikipedia.org/wiki/Heparan_sulfate">https://en.wikipedia.org/wiki/Heparan_sulfate</a></p><h4>IL33 : Interluken 33</h4><p>-”Cytokine that binds to and signals through the IL1RL1/ST2 receptor which in turn activates NF-kappa-B and MAPK signaling pathways in target cells (PubMed:<a href="https://www.uniprot.org/citations/16286016">16286016</a>). Involved in the maturation of Th2 cells inducing the secretion of T-helper type 2-associated cytokines. Also involved in activation of mast cells, basophils, eosinophils and natural killer cells. Acts as a chemoattractant for Th2 cells, and may function as an “alarmin”, that amplifies immune responses during tissue injury”</p><p>-Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension : <a href="https://www.sciencedirect.com/science/article/pii/S0006291X14011851?via%3Dihub">https://www.sciencedirect.com/science/article/pii/S0006291X14011851?via%3Dihub</a></p><p>-Pulmonary arterial hypertension caused by excess collagen deposition : <a href="http://www.phaonlineuniv.org/ResourceLibrary/Resource.cfm?ItemNumber=3886">http://www.phaonlineuniv.org/ResourceLibrary/Resource.cfm?ItemNumber=3886</a></p><h4>MPEG1 : Macrophage-expressed gene 1 protein</h4><p>-Pore-forming protein that attacks invading pathogens</p><p>-Specifically activated by LPS and TNFa signaling : <a href="https://www.ncbi.nlm.nih.gov/pubmed/28705375/">https://www.ncbi.nlm.nih.gov/pubmed/28705375/</a></p><p>-Along with <strong>Lgals3, </strong>this gene is overexpressed in muscular dystrophy mice: <a href="https://academic.oup.com/hmg/article-pdf/11/3/263/9464647/110263.pdf">https://academic.oup.com/hmg/article-pdf/11/3/263/9464647/110263.pdf</a></p><h4>NPC2 : NPC intracellular cholesterol transporter 2</h4><p><strong>- </strong>This appears to transport cholesterol out of the late endosomes, after cholesterol-containing lipoproteins are internalized. The fact that it is upregulated with age may suggest an enhanced reliance on cholesterol from external sources by many tissues.</p><p>- “Soluble NPC2 extracts cholesterol from endocytosed LDL and hands it over to the cholesterol-binding lumenal loop 1 of NPC1” : <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910236/figure/F1/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910236/figure/F1/</a></p><h4>ADIPOR2 : Adiponectin receptor 2</h4><p>-This is neat. Adiponectin is a hormone secreted in fat cells that has gotten attention in obesity. Blood adiponectin levels are inversely correlated with BMI</p><p>-What’s interesting about adiponectin itself: the official name is “adiponectin, C1Q and collagen domain containing”</p><p>- That’s right. It has a collagen domain and a C1q domain….. Yet another connection to that axis ….</p><p>- The structure also resembles that of TNF-a : <a href="https://www.cell.com/current-biology/fulltext/S0960-9822(98)70133-2?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0960982298701332%3Fshowall%3Dtrue">https://www.cell.com/current-biology/fulltext/S0960-9822(98)70133-2</a></p><p>- Adiponectin has been shown to be protective against atherosclerosis, and elevated leptin is bad : <a href="http://care.diabetesjournals.org/content/27/10/2488">http://care.diabetesjournals.org/content/27/10/2488</a></p><p>-Hypothesis: maybe adiponectin receptors are increased when adiponectin itself is lowered, as in obesity</p><h4>B2M</h4><p>-</p><h4>LITAF : lipopolysaccharide-induced TNF-α factor</h4><p>-This is the transcription factor that expresses TNF-a when the cell is stimulated by LPS: <a href="https://academic.oup.com/ibdjournal/article/12/7/581/4682732">https://academic.oup.com/ibdjournal/article/12/7/581/4682732</a></p><p>-Gee, I wonder if MPEG1 is activated by this transcription factor ….</p><h4>SERPING1 — Complement C1 inhibitor</h4><p><strong>-Directly inhibits the complement system to prevent spontaneous activation! : </strong><a href="https://en.wikipedia.org/wiki/C1-inhibitor"><strong>https://en.wikipedia.org/wiki/C1-inhibitor</strong></a></p><h4>HCST</h4><p>-</p><h4>RNF213</h4><p>-</p><h4>C4A : Complement component 4A</h4><p>-Complement proteins C3 and C4 bind to collagen and elastin in the vascular wall: a potential role in vascular stiffness and atherosclerosis: <a href="https://www.ncbi.nlm.nih.gov/pubmed/21707943">https://www.ncbi.nlm.nih.gov/pubmed/21707943</a></p><h4>SPP1 : Also known as osteopontin</h4><p>-Regulates bone ossification</p><p>-Has inflammatory roles: when phosphorylated it binds to integrin receptors on macrophages and polarizes them into the M1 proinflammatory state. A secret protein ACP5 (TRAP) has been observed in osteoclasts that dephosphorylates Osteopontin and returns macrophages to the M2 anti-inflammatory state.</p><p>-APOD binds to this gene and regulates its effect on cell migration.</p><p>-APOD and Osteopontin are highly coregulated in apoE knockout mice : “The top two induced genes were osteopontin (“OPN,” also called ”Spp1,” 416-fold increase) and apoD (80-fold increase); their expression levels in dKO mice increased with increasing age” — <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3801016/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3801016/</a></p><p>-Protects in ischemia : <a href="https://www.ncbi.nlm.nih.gov/pubmed/19337795">https://www.ncbi.nlm.nih.gov/pubmed/19337795</a></p><p>-Seems to be involved in inducing macrophage cleanup of beta-amyloid plaques : <a href="https://www.ncbi.nlm.nih.gov/pubmed/28860067">https://www.ncbi.nlm.nih.gov/pubmed/28860067</a></p><p>-Since its primary role is in regulating bone deposition and ossification, and has secondary roles in immune signaling, then it should be of no surprise that it is a core mechanism of blood vessel calcification : <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194039/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194039/</a></p><p>-This dataset doesn’t feature blood vessels, so I went looking for a gene expression study specific to atherosclerosis. Osteopontin is the most significantly upregulated gene : <a href="https://www.nature.com/articles/srep41483/tables/1">https://www.nature.com/articles/srep41483/tables/1</a></p><h4>CLIC4</h4><p>-</p><h4>EFEMP1 : EGF-containing fibulin-like extracellular matrix protein 1 (aka Fibulin 3 “FBLN3_HUMAN”)</h4><p>-Has many EGF-like calcium binding domains</p><p>-Part of the Fibulin family : Fibulin 1 has 3 Anaphylatoxin domains, which are highly homologous to C3a, the product of the complement C3 gene when it is activated. These domains don’t show up in uniprot for EFEMP1, but there may still be an interplay here with the complement system.</p><p>-Fibulin-1 is present in atherosclerotic plaques and colocalizes with macrophages and foam cells : <a href="https://www.ncbi.nlm.nih.gov/pubmed/19693531">https://www.ncbi.nlm.nih.gov/pubmed/19693531</a></p><h4>LAPTM5 : lysosomal-associated protein transmembrane 5</h4><p>-LAPTM5 Protein Is a Positive Regulator of Proinflammatory Signaling Pathways in Macrophages</p><p>“LAPTM5 facilitates activation of NF-κB and MAPK signaling and proinflammatory cytokine release mediated by cytokine and pattern recognition receptors.” <a href="http://www.jbc.org/content/287/33/27691.full">http://www.jbc.org/content/287/33/27691.full</a></p><h4>VAT1</h4><p>-</p><h4>HIST1H1C</h4><p>-</p><h4>KIAA0494</h4><p>-</p><h4>PTGES3 — Prostaglandin E synthase 3</h4><p>-Binds to progesterone receptor and HSP90</p><p>-Prostaglandins are synthesized from arachidonic acid (AA), and several papers indicate that <strong>APOD</strong>’s job is the reduction of peroxidized AA as well as its enzymatic products.</p><p>-”Facilitates HIF alpha proteins hydroxylation via interaction with EGLN1/PHD2, leading to recruit EGLN1/PHD2 to the HSP90 pathway” <a href="http://www.uniprot.org/uniprot/Q15185">http://www.uniprot.org/uniprot/Q15185</a> …. See the section on collagen for a discussion on HIF!</p><h4>LOC360231</h4><p><strong>-</strong></p><h4>RASA3</h4><p><strong>-</strong></p><h4>PSMD11</h4><p><strong>-</strong></p><h4>SGK1 : Serine/Threonine protein kinase, regulated by glucocorticoids, and activated by insulin axis and MTORC2</h4><p>-Genomic upregulation corresponds with cell death in parkinsons : <a href="https://en.wikipedia.org/wiki/SGK1">https://en.wikipedia.org/wiki/SGK1</a></p><p>-Phosphorylates TAU protein, causing it to aggregate in alzheimers : <a href="https://en.wikipedia.org/wiki/SGK1">https://en.wikipedia.org/wiki/SGK1</a></p><p>- Note, this isn’t the only thing claimed to phosphorylate TAU (see S100A6, also in this list)</p><h4>TXNIP : Thioredoxin binding protein</h4><p>-Thioredoxin : ROS scavenger and part of ROS signaling, mice overexpressing this live 35% longer : <a href="https://en.wikipedia.org/wiki/Thioredoxin">https://en.wikipedia.org/wiki/Thioredoxin</a></p><p>-Thioredoxin interacts with <strong>COL1A1</strong>, in our underexpressed gene list : <a href="https://linkinghub.elsevier.com/retrieve/pii/S0006291X02007271">https://linkinghub.elsevier.com/retrieve/pii/S0006291X02007271</a></p><p>“These data showed that the reducing status of TRX active site cysteine residues is important for the TRX–CP-pro α 1(1) interaction, indicating that collagen biosynthesis is under the regulation of TRX-dependent redox control.” — See the discussion below on collagen for why ROS may be relevant in collagen production</p><p>-Thioredoxin can directly activate or inhibit the complement system : <a href="https://www.ncbi.nlm.nih.gov/pubmed/22430737">https://www.ncbi.nlm.nih.gov/pubmed/22430737</a></p><p>-”Thioredoxin-interacting protein mediates high glucose-induced reactive oxygen species generation by mitochondria and the NADPH oxidase, Nox4, in mesangial cells.” : <a href="https://www.ncbi.nlm.nih.gov/pubmed/23329835">https://www.ncbi.nlm.nih.gov/pubmed/23329835</a></p><p>-TXNIP turns on NOX4, which produces ROS during ischemic stress</p><p>-Mice with TXNIP knocked out had far less collagen accumulation</p><p>Iah-VJ5558</p><p>HBA1</p><h4>HLA-G</h4><p>- Part of the MHCI complex, along with <strong>B2M</strong> above. This is a really atypical HLA gene, with much confusion on what it does.</p><p>- This paper however gives an excellent clue that ties into a lot of aging pathologies :<strong> Express and protect yourself: the potential role of HLA-G on muscle cells and in inflammatory myopathies </strong>: “Muscle is the site or the target of immunologic injury in several diseases. Whereas under physiologic conditions muscle fibers are negative for <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/major-histocompatibility-complex">major histocompatibility complex</a>(MHC) class I <a href="https://www.sciencedirect.com/topics/immunology-and-microbiology/antigen">antigens</a>, these are upregulated under pathologic conditions, thus rendering muscle a possible target for the recognition by cytotoxic CD8 T cells. Cultured muscle cells are capable of presenting antigens to <a href="https://www.sciencedirect.com/topics/immunology-and-microbiology/cd4">CD4</a> and CD8 T cells, further indicating that muscle fibers <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/in-vivo">in vivo</a> are critically involved in the initiating or perpetuating steps of inflammatory responses. The finding that muscle fibers in <a href="https://www.sciencedirect.com/topics/immunology-and-microbiology/autoimmunity">autoimmune</a> <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/inflammatory-myopathy">inflammatory myopathies</a> in vivoand cultured muscle cells <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/in-vitro">in vitro</a> express the nonclassical major histocompatibility complex molecule HLA-G raises several hypothesis concerning its possible <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/pathophysiology">pathophysiologic</a> role. We review present knowledge on the functional consequences of muscle-related HLA-G and provide concepts of its relevance under pathologic conditions. We further speculate on the potential therapeutic implications of HLA-G that relate to special approaches such as <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/myoblast">myoblast</a> transplantation or strategies against inflammatory aggression in general.” <a href="https://www.sciencedirect.com/science/article/pii/S0198885903005342?via%3Dihub">https://www.sciencedirect.com/science/article/pii/S0198885903005342?via%3Dihub</a></p><p>MSN</p><h4>PCSK6 : Proprotein convertase subtilisin/kexin type 6</h4><p>- “The protein encoded by this gene belongs to the <a href="https://en.wikipedia.org/wiki/Subtilisin">subtilisin</a>-like <a href="https://en.wikipedia.org/wiki/Proprotein_convertase">proprotein convertase</a> family. The members of this family are proprotein convertases that process latent precursor proteins into their biologically active products. This encoded protein is a <a href="https://en.wikipedia.org/wiki/Calcium_in_biology">calcium</a>-dependent serine <a href="https://en.wikipedia.org/wiki/Endoprotease">endoprotease</a> that can cleave precursor protein at their paired basic amino acid processing sites. Some of its substrates are — <a href="https://en.wikipedia.org/wiki/Transforming_growth_factor_beta">transforming growth factor beta</a> related proteins, proalbumin, and <a href="https://en.wikipedia.org/wiki/Von_Willebrand_factor"><strong>Willebrand factor</strong></a> <strong>(VMF in the overexpressed genes list)</strong>.”</p><p>- PCSK6 deficiency causes salt-sensitive hypertension in mice : PCSK6-mediated corin activation is essential for normal blood pressure <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710517/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710517/</a></p><p>TMED10</p><h3>Genes underexpressed with age, ranked:</h3><h4>TFRC : Transferrin receptor, important for iron uptake</h4><p>- Iron causes oxidative damage (via fenton reactions)</p><p>- This paper dicusssing iron’s connection with alzheimers, and its effects on cholesterol metabolism : <a href="https://www.frontiersin.org/articles/10.3389/fphar.2014.00165/full">https://www.frontiersin.org/articles/10.3389/fphar.2014.00165/full</a></p><p>- A role for iron deficiency in dopaminergic neurodegeneration : <a href="http://www.pnas.org/content/113/13/3417">http://www.pnas.org/content/113/13/3417</a></p><h4>COLLAGEN (3 genes) :</h4><p>A note on collagen … MUCH of the collagen protein is made of modified proline residues (hydroxyproline). The enzyme that catalyzes this reaction requires vitamin C (ascorbic acid), an O2, and Fe as a cofactor…… otherwise you get scurvy matey!</p><p>Required reading … I didn’t know much of this! <a href="https://en.wikipedia.org/wiki/Procollagen-proline_dioxygenase">https://en.wikipedia.org/wiki/Procollagen-proline_dioxygenase</a></p><p>Notable highlights:</p><ul><li>A highly reactive Fe(Iv)=O species is produced … iron enters this story yet again!</li><li>Oxygen is required, maybe hypoxia is bad</li><li>This article mentions that Hypoxia-Inducible-Factor (HIF) is targeted for degradation by similar hydroxylase enzymes … effectively a sensor to switch off that response pathway. Since ischemic stress appears to be a major theme in the cardiovascular disease, there is an interesting connection here</li></ul><p>I just learned this, and this is crazy, but here’s some gene numbers …. So collagen maybe</p><p>COL1A1</p><p>-”This is the most abundant collagen of the human body. It is present in <a href="https://en.wikipedia.org/wiki/Scar">scar tissue</a>, the end product when tissue <a href="https://en.wikipedia.org/wiki/Healing">heals</a> by repair. It is found in <a href="https://en.wikipedia.org/wiki/Tendon">tendons</a>, skin, artery walls, cornea, the <a href="https://en.wikipedia.org/wiki/Endomysium">endomysium</a> surrounding muscle fibers, fibrocartilage, and the organic part of bones and teeth.”</p><p>-Mutations lead to osteogenesis imperfecta, weak bones and irregular connective tissue</p><p>COL3A1</p><p>- “This is the collagen of <a href="https://en.wikipedia.org/wiki/Granulation_tissue">granulation tissue</a>, and is produced quickly by young fibroblasts before the tougher type I collagen is synthesized. <a href="https://en.wikipedia.org/wiki/Reticular_fiber">Reticular fiber</a>. Also found in artery walls, skin, intestines and the uterus”</p><p>-Mutations lead to Ehlers Danlos syndrome, can lead to bursting blood vessels</p><p>COL4A5</p><p>-”<a href="https://en.wikipedia.org/wiki/Basal_lamina">Basal lamina</a>; <a href="https://en.wikipedia.org/wiki/Eye_lens">eye lens</a>. Also serves as part of the filtration system in <a href="https://en.wikipedia.org/wiki/Capillaries"><strong>capillaries</strong></a> and the <a href="https://en.wikipedia.org/wiki/Glomeruli">glomeruli</a> of <a href="https://en.wikipedia.org/wiki/Nephron">nephron</a> in the <a href="https://en.wikipedia.org/wiki/Kidney">kidney</a>.”</p><h4>FABP3 : Heart type fatty acid binding protein</h4><p>-Released by heart cells after an acute ischemic episode : <a href="https://en.wikipedia.org/wiki/Heart-type_fatty_acid_binding_protein">https://en.wikipedia.org/wiki/Heart-type_fatty_acid_binding_protein</a></p><p>- It is a highly sensitive of heart attacks showing just hours after pain starts — perhaps this indicates that aging is associated with progressive hypoxia throughout the circulatory system …. and/or mitochondrial dysfunction since its role is the transport of long-chain fatty acids to the mitochondria</p><h4>ATP5G3 : subunit of ATP-synthase — this subunit encodes part of the proton channel</h4><p>-This paper discusses “Housekeeping Genes” (HKGs) that are typically used to normalize gene expression experiments. <a href="https://www.nature.com/articles/6605573">https://www.nature.com/articles/6605573</a></p><p><em>“The expression pattern of 10 commonly used HKG (namely ATP synthase (ATP5G3), β-2-microglobulin (B2M), ACTB, β-glucuronidase (GUSB), ophilin A (PPIA), GAPDH, hypoxanthine ribosyltransferase (HPRT1), phosphoglycerokinase (PGK1), TATA-box-binding protein (TBP) and transferrin receptor (TFRC)) was investigated by qRT-PCR in different cell lines cultured in various hypoxic or aerobic conditions.”</em></p><p>Thus, since these are housekeeping genes used in normalization. It might be that ATPG3 and TFRC are false positives. On the other hand, the whole point of this paper is discussing how hypoxia modulates these pathways</p><p><em>“Altogether, these results confirm that HKGs used for normalising gene expression in qRT-PCR may vary. Moreover, they emphasise that HKGs may dramatically fluctuate according to hypoxic conditions.”</em>!</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/499/0*DPqo3xVDeGVqnomJ" /></figure><h4>NDUFB11 : NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11</h4><p>- Part of complex 1 in the electron transport chain. Favorite gene of Francesca and I. Complex 1 is the primary site of ROS generation, and is also dependent on Iron-Sulphur clusters for electron transport activity. Metformin is thought to act at this enzyme, possibly for its life-extending effects.</p><p>-Muscle and Kidney, in both humans and mice, appear to be the tissues where it is underexpressed in aging.</p><p>- “<a href="https://www.omim.org/entry/300403#4">Kohda et al. (2016)</a> found that knockdown of the Ndufb11 gene in Drosophila resulted in significantly reduced lifespan, decreased metabolic rate, loss of mitochondrial complex I assembly, and increased lactate and pyruvate.” <a href="https://www.omim.org/entry/300403">https://www.omim.org/entry/300403</a></p><p>-Mutations in this gene cause complex 1 deficiency, which I have. Yay</p><h4>CX3CL1 : Fractalkine precursor</h4><p>-This ligand attracts T-cells and monocytes when solubilized. When expressed in the membrane of an epithelial cell, binds and activates leukocytes : <a href="https://en.wikipedia.org/wiki/CX3CL1">https://en.wikipedia.org/wiki/CX3CL1</a></p><p>-Binds to the chemokine receptor CX3CR1. In the brain, this pathway regulates movement and activation of microglia and affects severity of ALS progression</p><h4>CA4 : Carbonic anhydrase 4 — The wikipedia article is fascinating … suggests that lack of carbon dioxide transport out of the lungs may be affected by age</h4><p>-Carbonic anhydrases (CAs) are a large family of zinc metalloenzymes that catalyze the reversible hydration of carbon dioxide. <a href="https://en.wikipedia.org/wiki/Carbonic_anhydrase_4">https://en.wikipedia.org/wiki/Carbonic_anhydrase_4</a></p><p>-”CA IV has been identified in pulmonary epithelium of many mammalian species and may be uniquely adaptive for gas exchange necessary for the high metabolic requirements of mammals. A majority of the CO2 produced by metabolism is transported as bicarbonate (HCO3-). At the tissue capillary, CO2 diffuses from tissue to plasma. Other forms of carbonic anhydrase enzyme are not present in the plasma, restricting the equilibrium reaction of CO2+H2O = H2CO3 = H+ HCO3-. CO2 in the plasma diffuses into the Red Blood Cell. CA is present within the Red Blood Cell, facilitating the conversion of CO2 to HCO3-. HCO3- so produced is transferred by the HCO3-/Cl- “shuttle” from the interior of the Red Blood Cell to the plasma. HCO3- doers not diffuse across cell membranes and, in the absence of CA, stays as HCO3- and concentrates in plasma. Up to 80% of metabolically produced CO2 is transported in plasma in the form of HCO3-. Blood moves from the tissue capillary to the pulmonary capillary where CO2 is exchanged at the lung.”</p><p>-This paper suggests that carbonic anhydrase 2 limits longevity : <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5115898/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5115898/</a></p><p>-A google search for “carbonic anhydrase longevity” turns up MANY hits — lots of popscience ….</p><h4>CALB1 : calbindin 1</h4><p>-Has 6 EF-hand motifs that bind calcium. This gene is vitamin-D responsive, and is considered to be primarily responsible for regulating calcium uptake, particularly in the intensine</p><p>-Calcium seems central to a few things in this dataset. S100A proteins also include EF-hands, and EFEMP1</p><h4>GHITM : Growth hormone-inducible transmembrane protein</h4><p>-Localizes to inner mitochondrial membrane and ER. Significantly upregulated by growth hormone. Appears to inhibit apoptosis. This gene directly regulates the release of cytochrome C from the matrix space, which is an important initiator of the apoptotic cascade.</p><p>-This gene didn’t catch my attention until I saw this twitter thread today : <a href="https://twitter.com/kevinnbass/status/1002796143816904704">https://twitter.com/kevinnbass/status/1002796143816904704</a></p><p>Highlights :</p><p>- Short people live longer (jerks!). Height is negatively associated with longevity, and this might a lot of why okinawans live so long!</p><p>-There is a rare genetic disorder called Laron’s syndrome, which causes dwarfism. People with this disease have a 0% cancer rate …. They are also protected against insulin resistance. (suggests better mito, I think)</p><p>- So, one possibility is that with excess growth hormone, apoptosis is inhibited. Turn off GH, (or better yet, target this gene with a drug), and cells will be more likely to enter apoptosis</p><p>UQCRQ</p><p>“This gene encodes a ubiquinone-binding protein of low molecular mass. This protein is a small core-associated protein and a subunit of ubiquinol-cytochrome c reductase complex III, which is part of the mitochondrial respiratory chain.”</p><p><a href="https://en.wikipedia.org/wiki/UQCRQ">https://en.wikipedia.org/wiki/UQCRQ</a></p><p>- The fact that this is ubiquinone binding is interesting. The cofactor binding site is certainly required for electron transport!</p><h4>C5ORF13: Renamed NREP :</h4><p>- Also known as PTZ17, this gene is regulated by <strong>Metalothionen</strong> (an overexpressed gene in this dataset). This gene requires metalothionen expression to be expressed : <a href="https://www.ncbi.nlm.nih.gov/pubmed/10981724">https://www.ncbi.nlm.nih.gov/pubmed/10981724</a></p><p>- Regulates smooth muscle development. When expressed in myofibroblasts, it suppresses TGF-beta signaling and collagen 1+3 expression. The authors conclude that this gene is protective of fibrosis — too bad it’s underexpressed! : <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC151607/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC151607/</a></p><h4>ACCS2: Cytoplasmic acetyl-coa synthetase</h4><p>-Makes acetyl-coa from acetate, required for histone acetylation and energy metabolism. Activated by the SREBP axis, which are transcription factors that upregulate lipid and cholesterol synthesis <a href="https://en.wikipedia.org/wiki/ACSS2">https://en.wikipedia.org/wiki/ACSS2</a></p><p>- If this is underexpressed, it could be that gene expression is hindered, but it has been shown that ACCS2 translocates to the nucleus in hypoxic tumors : <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5276806/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5276806/</a></p><p>- This gene controls HIF-2 signaling in hypoxic cells : <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159437/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159437/</a></p><p>- “Biosynthesis of cholesterol generally takes place in the endoplasmic reticulum of hepatic cells and begins with acetyl- CoA, which is mainly derived from an oxidation reaction in the mitochondria. However, acetyl-CoA can also be derived from the cytoplasmic oxidation of ethanol by acetyl-CoA synthetase.” <a href="https://www.sigmaaldrich.com/technical-documents/articles/biofiles/cholesterol-biosynthesis.html">https://www.sigmaaldrich.com/technical-documents/articles/biofiles/cholesterol-biosynthesis.html</a></p><p>- This suggests that if mitochondria are compromised, and ACCS2 expression is down, the cell is reliant on cholesterol delivery from LDL particles!</p><p>- Cholesterol synthesis is activated by SREBP-2, whereas SREBP-1 is more for denovo lipogenesis and storage of fat droplets. Interestingly, this paper shows that ROS exposure to cells induces SREBP-2 and not SREBP-1 expression : <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523558/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523558/</a></p><p>- SREBP-2 downregulates the APOE receptor LPR1, but directly upregulates the LDL Receptor (LDLR) with sterol regulatory elements (SREs) in the sequence : <a href="https://www.sciencedirect.com/science/article/pii/S1550413105001142">https://www.sciencedirect.com/science/article/pii/S1550413105001142</a></p><p>- ACCS2 is a direct target of SREBP-2, implying that when the cell needs cholesterol, its supposed to upregulate cytosolic synthesis of acetyl-coa….</p><h4>UQCRFS1 : Ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1</h4><p>- This is another subunit of mitochondrial complex 3 (along with UQCRQ). This subunit binds an iron-sulphur cluster that is required for electron transport.</p><h4>DIABLO : SMAC (second mitochondria-derived activator of caspases)</h4><p>-A pro-apoptotic factor</p><p>Genetics of Cardiovascular disease</p><p>Since so many of these aging genes in the expression data seem to resemble pathways in atherosclerosis … lets try and find connections with GWAS. <a href="http://embomolmed.embopress.org/content/8/7/688">http://embomolmed.embopress.org/content/8/7/688</a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=6e4e7ccae964" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>